BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weinberg RA. Tumor suppressor genes. Science. 1991;254:1138-1146. [PMID: 1659741 DOI: 10.1126/science.1659741] [Cited by in Crossref: 1002] [Cited by in F6Publishing: 853] [Article Influence: 33.4] [Reference Citation Analysis]
Number Citing Articles
1 Pawelek JM, Chakraborty AK. The cancer cell--leukocyte fusion theory of metastasis. Adv Cancer Res. 2008;101:397-444. [PMID: 19055949 DOI: 10.1016/s0065-230x(08)00410-7] [Cited by in Crossref: 104] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
2 Shaulian E, Zauberman A, Ginsberg D, Oren M. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 1992;12:5581-92. [PMID: 1448088 DOI: 10.1128/mcb.12.12.5581-5592.1992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 118] [Article Influence: 0.1] [Reference Citation Analysis]
3 Nettleton JA. Omega-3 Fatty Acids in Other Diseases. Omega-3 Fatty Acids and Health. Boston: Springer US; 1995. pp. 287-354. [DOI: 10.1007/978-1-4615-2071-9_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Sato M, Harada K, Bando T, Shirakami T, Nakashiro K, Yoshida H, Nakai S, Kawai K, Adachi M. Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice. Cancer Lett 1995;91:1-9. [PMID: 7750082 DOI: 10.1016/0304-3835(95)03713-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
5 Dergham ST, Dugan MC, Joshi US, Chen YC, Du W, Smith DW, Arlauskas P, Crissman JD, Vaitkevicius VK, Sarkar FH. The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma. Cancer 1997;80:372-81. [PMID: 9241070 DOI: 10.1002/(sici)1097-0142(19970801)80:3<372::aid-cncr4>3.0.co;2-u] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
6 Trouche D, Le Chalony C, Muchardt C, Yaniv M, Kouzarides T. RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci U S A 1997;94:11268-73. [PMID: 9326598 DOI: 10.1073/pnas.94.21.11268] [Cited by in Crossref: 195] [Cited by in F6Publishing: 212] [Article Influence: 8.1] [Reference Citation Analysis]
7 Kong XT, Choi SH, Bessho F, Kobayashi M, Hanada R, Yamamoto K, Hayashi Y. Codon 201(Gly) polymorphic type of the DCC gene is related to disseminated neuroblastoma. Neoplasia 2001;3:267-72. [PMID: 11571626 DOI: 10.1038/sj.neo.7900169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
8 Patel S, Fisher LM. Novel selection and genetic characterisation of an etoposide-resistant human leukaemic CCRF-CEM cell line. Br J Cancer 1993;67:456-63. [PMID: 8382508 DOI: 10.1038/bjc.1993.87] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
9 Tang S, Jiang H, Cao Z, Zhou Q. Down-regulation of miR-219-5p increase the risk of cancer-related mortality in patients with prostate cancer. Postgrad Med J 2021:postgradmedj-2021-139981. [PMID: 33879548 DOI: 10.1136/postgradmedj-2021-139981] [Reference Citation Analysis]
10 Chen SY, Thakur A, Miller AS, Harwick RD. Rhabdomyosarcoma of the oral cavity. Report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:192-201. [PMID: 7552885 DOI: 10.1016/s1079-2104(05)80202-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Dunn J, Garde J, Dolan K, Gosney JR, Sutton R, Meltzer SJ, Field JK. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer. Oncogene 1999;18:987-93. [DOI: 10.1038/sj.onc.1202371] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
12 Hallek M, Leif Bergsagel P, Anderson KC. Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process. Blood 1998;91:3-21. [DOI: 10.1182/blood.v91.1.3] [Cited by in Crossref: 538] [Article Influence: 23.4] [Reference Citation Analysis]
13 Onadim Z, Hogg A, Baird PN, Cowell JK. Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci U S A 1992;89:6177-81. [PMID: 1352883 DOI: 10.1073/pnas.89.13.6177] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 2.7] [Reference Citation Analysis]
14 Kurose K, Bando K, Fukino K, Sugisaki Y, Araki T, Emi M. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles. Jpn J Cancer Res 1998;89:842-8. [PMID: 9765621 DOI: 10.1111/j.1349-7006.1998.tb00638.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
15 Noubissi FK, Harkness T, Alexander CM, Ogle BM. Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis. FASEB J. 2015;29:4036-4045. [PMID: 26085132 DOI: 10.1096/fj.15-271098] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
16 Zhang S, Liu S, Goodrow T, Morris R, Klein-szanto AJ. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms. Mol Carcinog 1997;18:142-52. [DOI: 10.1002/(sici)1098-2744(199703)18:3<142::aid-mc3>3.0.co;2-h] [Cited by in Crossref: 30] [Article Influence: 1.3] [Reference Citation Analysis]
17 Sawyer JR, Sammartino G, Husain M, Boop FA, Chadduck WM. Chromosome aberrations in four ependymomas. Cancer Genetics and Cytogenetics 1994;74:132-8. [DOI: 10.1016/0165-4608(94)90011-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
18 Destrée OH, Lam KT, Peterson-maduro L, Eizema K, Diller L, Gryka MA, Frebourg T, Shibuya E, Friend SH. Structure and expression of the Xenopus retinoblastoma gene. Developmental Biology 1992;153:141-9. [DOI: 10.1016/0012-1606(92)90098-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
19 Butcher M, Frenck R, Emperor J, Paderanga D, Maybee D, Olson K, Shannon K. Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders. Genes Chromosom Cancer 1995;12:50-7. [DOI: 10.1002/gcc.2870120109] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
20 Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. TheSOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma byp53 andXRCC1 polymorphisms. Cancer 2004;101:2802-8. [DOI: 10.1002/cncr.20716] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
21 Olsson I, Bergh G, Ehinger M, Gullberg U. Cell differentiation in acute myeloid leukemia. European Journal of Haematology 1996;57:1-16. [DOI: 10.1111/j.1600-0609.1996.tb00483.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
22 Hiebert SW. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 1993;13:3384-91. [PMID: 8497257 DOI: 10.1128/mcb.13.6.3384-3391.1993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 48] [Article Influence: 0.1] [Reference Citation Analysis]
23 Agrawal RS, Agrawal YP, Mäntyjärvi RA. Flow cytometric quantitation of C-myc and P53 proteins in bovine papillomavirus type 1-transformed primary mouse fibroblasts. Cytometry 1994;17:237-45. [PMID: 7851159 DOI: 10.1002/cyto.990170307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
24 Viney JL. Transgenic and gene knockout mice in cancer research. Cancer Metast Rev 1995;14:77-90. [DOI: 10.1007/bf00665792] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
25 Lafky JM, Wilken JA, Baron AT, Maihle NJ. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 2008;1785:232-65. [PMID: 18291115 DOI: 10.1016/j.bbcan.2008.01.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 97] [Article Influence: 2.5] [Reference Citation Analysis]
26 Smith MR, Matthews NT, Jones KA, Kung H. Biological actions of oncogenes. Pharmacology & Therapeutics 1993;58:211-36. [DOI: 10.1016/0163-7258(93)90050-n] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
27 Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol Cell Biol 1997;17:1049-56. [PMID: 9032231 DOI: 10.1128/MCB.17.3.1049] [Cited by in Crossref: 58] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
28 Tsirigotis P, Pappa V, Labropoulos S, Papageorgiou S, Kontsioti F, Dervenoulas J, Papageorgiou E, Panani A, Mantzios G, Economopoulos T, Raptis S. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia. Eur J Haematol 2006;76:230-6. [DOI: 10.1111/j.1600-0609.2005.00604.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
29 Liebermann DA, Hoffman B. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Stem Cells 1994;12:352-69. [DOI: 10.1002/stem.5530120402] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.6] [Reference Citation Analysis]
30 Chalkley GE, Knowles PP, Whitehead PC, Coffer AI. Biochemical characterisation of purified human wild-type p53 overexpressed in insect cells. Eur J Biochem 1994;221:167-75. [DOI: 10.1111/j.1432-1033.1994.tb18726.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
31 Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI. Codeletion ofCDKN2 andMTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosom Cancer 1998;22:72-8. [DOI: 10.1002/(sici)1098-2264(199805)22:1<72::aid-gcc10>3.0.co;2-k] [Cited by in Crossref: 41] [Article Influence: 1.8] [Reference Citation Analysis]
32 Jay M, McCartney AC. Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol 1993;37:457-62. [PMID: 8516755 DOI: 10.1016/0039-6257(93)90142-t] [Cited by in Crossref: 35] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
33 Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857-866. [PMID: 17060945 DOI: 10.1038/nrc1997] [Cited by in Crossref: 5257] [Cited by in F6Publishing: 4827] [Article Influence: 375.5] [Reference Citation Analysis]
34 Florin-christensen M, Missero C, Dotto G, Florin-christensen J. The E1a gene prevents inhibition of keratinocyte proliferation by dexamethasone. Experimental Cell Research 1992;203:285-8. [DOI: 10.1016/0014-4827(92)90067-i] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Feigenbaum L, Fujita K, Collins FS, Jay G. Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice. J Virol 1996;70:3280-5. [PMID: 8627811 DOI: 10.1128/JVI.70.5.3280-3285.1996] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
36 Stanton SE, Shin SW, Johnson BE, Meyerson M. Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas. Genes Chromosomes Cancer 2000;27:323-31. [DOI: 10.1002/(sici)1098-2264(200003)27:3<323::aid-gcc14>3.0.co;2-p] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
37 Claycomb WC. Control of cardiac muscle cell division. Trends in Cardiovascular Medicine 1992;2:231-6. [DOI: 10.1016/1050-1738(92)90030-v] [Cited by in Crossref: 47] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
38 Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T, Fukushima T. Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas. J Neurooncol 2007;83:153-62. [DOI: 10.1007/s11060-006-9316-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
39 Frebourg T, Friend SH. Cancer risks from germline p53 mutations. J Clin Invest 1992;90:1637-41. [PMID: 1430194 DOI: 10.1172/JCI116034] [Cited by in Crossref: 54] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
40 Bartesaghi S, Salomoni P. Tumor suppressive pathways in the control of neurogenesis. Cell Mol Life Sci 2013;70:581-97. [DOI: 10.1007/s00018-012-1063-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
41 Behm FG. Diagnosis of Childhood Acute Myeloid Leukemia. Clinics in Laboratory Medicine 1999;19:187-238. [DOI: 10.1016/s0272-2712(18)30135-5] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
42 Reshmi SC, Gollin SM. Chromosomal instability in oral cancer cells. J Dent Res 2005;84:107-17. [PMID: 15668327 DOI: 10.1177/154405910508400203] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
43 Chim CS, Tam CY, Liang R, Kwong YL. Methylation ofp15 andp16 genes in adult acute leukemia: Lack of prognostic significance. Cancer 2001;91:2222-9. [DOI: 10.1002/1097-0142(20010615)91:12<2222::aid-cncr1252>3.0.co;2-r] [Cited by in Crossref: 51] [Cited by in F6Publishing: 1] [Article Influence: 2.6] [Reference Citation Analysis]
44 Nelson SF. Genomic mismatch scanning: Current progress and potential applications. Electrophoresis 1995;16:279-85. [DOI: 10.1002/elps.1150160144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
45 Trosko JE, Kang KS. Evolution of energy metabolism, stem cells and cancer stem cells: how the warburg and barker hypotheses might be linked. Int J Stem Cells 2012;5:39-56. [PMID: 24298354 DOI: 10.15283/ijsc.2012.5.1.39] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
46 Popescu NC, Zimonjic DB. Molecular cytogenetic characterization of cancer cell alterations. Cancer Genet Cytogenet 1997;93:10-21. [PMID: 9062575 DOI: 10.1016/s0165-4608(96)00262-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
47 Garkavtsev I, Kazarov A, Gudkov A, Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet. 1996;14:415-420. [PMID: 8944021 DOI: 10.1038/ng1296-415] [Cited by in Crossref: 202] [Cited by in F6Publishing: 191] [Article Influence: 8.4] [Reference Citation Analysis]
48 Figge J, Breese K, Vajda S, Zhu QL, Eisele L, Andersen TT, MacColl R, Friedrich T, Smith TF. The binding domain structure of retinoblastoma-binding proteins. Protein Sci 1993;2:155-64. [PMID: 8382993 DOI: 10.1002/pro.5560020204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
49 Funk WD, Pak DT, Karas RH, Wright WE, Shay JW. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 1992;12:2866-71. [PMID: 1588974 DOI: 10.1128/mcb.12.6.2866-2871.1992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 221] [Article Influence: 0.2] [Reference Citation Analysis]
50 Holland ND, Zhang S, Clark M, Panopoulou G, Lehrach H, Holland LZ. Sequence and developmental expression ofAmphiTob, an amphioxus homolog of vertebrateTob in thePC3/BTG1/Tob family of tumor suppressor genes. Dev Dyn 1997;210:11-8. [DOI: 10.1002/(sici)1097-0177(199709)210:1<11::aid-aja2>3.0.co;2-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
51 Yu A, Hashimura T, Nishio Y, Kanamaru H, Fukuzawa S, Yoshida O. Anti-promoting effect of nordihydroguaiaretic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine and sodium saccharin-induced rat urinary bladder carcinogenesis. Jpn J Cancer Res 1992;83:944-8. [PMID: 1429204 DOI: 10.1111/j.1349-7006.1992.tb02005.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
52 Tomuleasa C, Fuji S, Cucuianu A, Kapp M, Pileczki V, Petrushev B, Selicean S, Tanase A, Dima D, Berindan-Neagoe I, Irimie A, Einsele H. MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation. Ann Hematol 2015;94:1081-92. [PMID: 25900787 DOI: 10.1007/s00277-015-2369-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
53 Antignac C, Zhou J, Sanak M, Cochat P, Roussel B, Deschênes G, Gros F, Knebelmann B, Hors-Cayla MC, Tryggvason K. Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene. Kidney Int 1992;42:1178-83. [PMID: 1453602 DOI: 10.1038/ki.1992.402] [Cited by in Crossref: 73] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
54 Bhatia S, Kaul D, Varma N. Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia. Mol Cell Biochem 2011;346:103-16. [PMID: 20924650 DOI: 10.1007/s11010-010-0597-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
55 Umesako S, Iiga S, Takahashi M, Imura K, Mori N, Hong D, Song C, Niwa O, Okumoto M. Distinct Pattern of Allelic Loss and Inactivation of Cadherin 1 and 5 Genes in Mammary Carcinomas Arising in p53+/- Mice. JRR 2007;48:143-52. [DOI: 10.1269/jrr.06064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
56 Queimado L, Seruca R, Costa-Pereira A, Castedo S. Identification of two distinct regions of deletion at 6q in gastric carcinoma. Genes Chromosomes Cancer 1995;14:28-34. [PMID: 8527381 DOI: 10.1002/gcc.2870140106] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 1.3] [Reference Citation Analysis]
57 Bergh G, Ehinger M, Olofsson T, Baldetorp B, Johnsson E, Brycke H, Lindgren G, Olsson I, Gullberg U. Altered Expression of the Retinoblastoma Tumor-Suppressor Gene in Leukemic Cell Lines Inhibits Induction of Differentiation But Not G1-Accumulation. Blood 1997;89:2938-50. [DOI: 10.1182/blood.v89.8.2938] [Cited by in Crossref: 28] [Article Influence: 1.2] [Reference Citation Analysis]
58 Wadhwa R, Kaul S, Sugimoto Y, Mitsui Y. Induction of cellular senescence by transfection of cytosolic mortalin cDNA in NIH 3T3 cells. Journal of Biological Chemistry 1993;268:22239-42. [DOI: 10.1016/s0021-9258(18)41515-3] [Cited by in Crossref: 44] [Article Influence: 1.6] [Reference Citation Analysis]
59 Samimi H, Zaki Dizaji M, Ghadami M, Shahzadeh Fazeli A, Khashayar P, Soleimani M, Larijani B, Haghpanah V. Essential genes in thyroid cancers: focus on fascin. J Diabetes Metab Disord 2013;12:32. [PMID: 23815863 DOI: 10.1186/2251-6581-12-32] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
60 Kang S, Folk WR. Lymphotropic papovavirus transforms hamster cells without altering the amount or stability of p53. Virology 1992;191:754-64. [DOI: 10.1016/0042-6822(92)90251-j] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Harper JW. Cyclin dependent kinase inhibitors. Cancer Surv. 1997;29:91-107. [PMID: 9338098 DOI: 10.1002/(SICI)1521-1878(199812)20:12%3C1020::AID-BIES8%3E3.0.CO;2-D] [Reference Citation Analysis]
62 Kristie T, Sharp P. Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus alpha-trans-induction factor (VP16). Journal of Biological Chemistry 1993;268:6525-34. [DOI: 10.1016/s0021-9258(18)53282-8] [Cited by in Crossref: 66] [Article Influence: 2.4] [Reference Citation Analysis]
63 Yan W, West A, Toppari J, Lähdetie J. Stage-specific expression and phosphorylation of retinoblastoma protein (pRb) in the rat seminiferous epithelium. Molecular and Cellular Endocrinology 1997;132:137-48. [DOI: 10.1016/s0303-7207(97)00129-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
64 Gutmann DH, Cole JL, Stone WJ, Ponder BA, Collins FS. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. Genes Chromosomes Cancer 1994;10:55-8. [PMID: 7519874 DOI: 10.1002/gcc.2870100109] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 1.9] [Reference Citation Analysis]
65 Berchuck A, Boyd J. Molecular basis of endometrial cancer. Cancer 1995;76:2034-40. [DOI: 10.1002/1097-0142(19951115)76:10+<2034::aid-cncr2820761321>3.0.co;2-u] [Cited by in Crossref: 63] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
66 Ko YH, Choi KE, Han JH, Kim JM, Ree HJ. Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. Cytometry 2001;46:85-91. [PMID: 11309817 DOI: 10.1002/cyto.1069] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
67 el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet. 1992;1:45-49. [PMID: 1301998 DOI: 10.1038/ng0492-45] [Cited by in Crossref: 1317] [Cited by in F6Publishing: 1322] [Article Influence: 47.0] [Reference Citation Analysis]
68 Rao JY, Bonner RB, Hurst RE, Liang YY, Reznikoff CA, Hemstreet GP 3rd. Quantitative changes in cytoskeletal and nuclear actins during cellular transformation. Int J Cancer 1997;70:423-9. [PMID: 9033650 DOI: 10.1002/(sici)1097-0215(19970207)70:4<423::aid-ijc9>3.0.co;2-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
69 Hu Y, Benya RV, Carroll RE, Diamond AM. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 2005;135:3021S-4S. [PMID: 16317164 DOI: 10.1093/jn/135.12.3021S] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
70 Iengar P. An analysis of substitution, deletion and insertion mutations in cancer genes. Nucleic Acids Res. 2012;40:6401-6413. [PMID: 22492711 DOI: 10.1093/nar/gks290] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
71 Furihata M, Sonobe H, Ohtsuki Y, Yamashita M, Morioka M, Yamamoto A, Terao N, Kuwahara M, Fujisaki N. DETECTION OF p53 AND bcl-2 PROTEIN IN CARCINOMA OF THE RENAL PELVIS AND URETER INCLUDING DYSPLASIA. J Pathol 1996;178:133-9. [DOI: 10.1002/(sici)1096-9896(199602)178:2<133::aid-path455>3.0.co;2-f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
72 Chen YF, Chiu HH, Wu CH, Wang JY, Chen FM, Tzou WH, Shin SJ, Lin SR. Retinoblastoma protein (pRB) was significantly phosphorylated through a Ras-to-MAPK pathway in mutant K-ras stably transfected human adrenocortical cells. DNA Cell Biol 2003;22:657-64. [PMID: 14611687 DOI: 10.1089/104454903770238139] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
73 Diaz-cano SJ. Clonality studies in the analysis of adrenal medullary proliferations: Application principles and limitations. Endocr Pathol 1998;9:301-16. [DOI: 10.1007/bf02739690] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
74 Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature. 1992;359:295-300. [PMID: 1406933 DOI: 10.1038/359295a0] [Cited by in Crossref: 1163] [Cited by in F6Publishing: 1118] [Article Influence: 40.1] [Reference Citation Analysis]
75 Gelli E, Fallerini C, Valentino F, Giliberti A, Castiglione F, Laschi L, Palmieri M, Fabbiani A, Tita R, Mencarelli MA, Renieri A, Ariani F. RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report. Front Oncol 2020;10:1467. [PMID: 32974172 DOI: 10.3389/fonc.2020.01467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104:593-604. [PMID: 11239415 DOI: 10.1016/s0092-8674(01)00245-8] [Cited by in Crossref: 424] [Cited by in F6Publishing: 205] [Article Influence: 21.2] [Reference Citation Analysis]
77 Dees C, Travis C. Phenotypic and genotypic analysis of rat liver epithelial cells infected with retroviral shuttle vectors. Cancer Lett 1996;107:19-28. [PMID: 8913262 DOI: 10.1016/0304-3835(96)04338-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
78 Awazu S, Nakata K, Hida D, Sakamoto T, Nagata K, Ishii N, Kanematsu T. Stable Transfection of Retinoblastoma Gene Promotes Contact Inhibition of Cell Growth and Hepatocyte Nuclear Factor-1-Mediated Transcription in Human Hepatoma Cells. Biochemical and Biophysical Research Communications 1998;252:269-73. [DOI: 10.1006/bbrc.1998.9623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
79 Hewett PJ, Firgaira F, Morley A. A COMPARISON OF SOUTHERN BLOT AND POLYMERASE CHAIN REACTION AS TECHNIQUES TO IDENTIFY LOSS OF DNA HETEROZYGOSITY IN COLORECTAL CANCER. ANZ J Surg 1994;64:556-7. [DOI: 10.1111/j.1445-2197.1994.tb02285.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
80 Miyamoto C, Sant’anna J, Franco C, Castro-prado M. Genotoxicity (mitotic recombination) of the cancer chemotherapeutic agents cisplatin and cytosine arabinoside in Aspergillus nidulans. Food and Chemical Toxicology 2007;45:1091-5. [DOI: 10.1016/j.fct.2006.12.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
81 Sakashita N, Takeya M, Kishida T, Stackhouse TM, Zbar B, Takahashi K. Expression of von Hippel-Lindau protein in normal and pathological human tissues. Histochem J. 1999;31:133-144. [PMID: 10416685 DOI: 10.1023/a:1003554712386] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
82 Nowak MA, Michor F, Iwasa Y. The linear process of somatic evolution. Proc Natl Acad Sci U S A 2003;100:14966-9. [PMID: 14657359 DOI: 10.1073/pnas.2535419100] [Cited by in Crossref: 131] [Cited by in F6Publishing: 82] [Article Influence: 7.3] [Reference Citation Analysis]
83 Nilson LA, DiMaio D. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol Cell Biol 1993;13:4137-45. [PMID: 8321218 DOI: 10.1128/mcb.13.7.4137-4145.1993] [Cited by in Crossref: 48] [Article Influence: 1.7] [Reference Citation Analysis]
84 Salazar A, Ostrosky-wegman P, Menéndez D, Miranda E, Garcı́a-carrancá A, Rojas E. Induction of p53 protein expression by sodium arsenite. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1997;381:259-65. [DOI: 10.1016/s0027-5107(97)00207-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
85 Neubauer A, Richiero K, Huhn D. Alterations of the Retinoblastoma a Susceptibility Gene in Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 2009;18:399-404. [DOI: 10.3109/10428199509059637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
86 Farrell RE, Greene JJ. Regulation of c-myc and c-Ha-ras oncogene expression by cell shape. J Cell Physiol 1992;153:429-35. [DOI: 10.1002/jcp.1041530223] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
87 Dergham ST, Dugan MC, Joshi US, Chen YC, Du W, Smith DW, Arlauskas P, Crissman JD, Vaitkevicius VK, Sarkar FH. The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma. Cancer. 1997;80:372-381. [PMID: 9241070 DOI: 10.1002/(SICI)1097-0142(19970801)80:3%3C372::AID-CNCR4%3E3.0.CO;2-U] [Reference Citation Analysis]
88 Han JS, N��ez G, Wicha MS, Clarke MF. Targeting cancer cell death with a bcl-xS adenovirus. Springer Semin Immunopathol 1998;19:279-88. [DOI: 10.1007/bf00787225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
89 Uchida T, Kinoshita T, Saito H, Hotta T. CDKN2 (MTS1/p16 INK4A ) Gene Alterations in Hematological Malignancies. Leukemia & Lymphoma 2009;24:449-61. [DOI: 10.3109/10428199709055583] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
90 Roth JA, Cristiano RJ. Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst. 1997;89:21-39. [PMID: 8978404 DOI: 10.1093/jnci/89.1.21] [Cited by in Crossref: 436] [Cited by in F6Publishing: 348] [Article Influence: 18.2] [Reference Citation Analysis]
91 Liu PK, Trujillo JM, Monnat RJ Jr. Spectrum of spontaneous mutation in animal cells containing an aphidicolin-resistant DNA polymerase alpha. Mutat Res 1993;288:229-36. [PMID: 7688082 DOI: 10.1016/0027-5107(93)90089-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
92 Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 1997;17:7268-82. [PMID: 9372959 DOI: 10.1128/MCB.17.12.7268] [Cited by in Crossref: 144] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
93 Filvaroff E, Ebner R, Derynck R. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor. Development 1994;120:1085-95. [DOI: 10.1242/dev.120.5.1085] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
94 Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, Platt J, Bermudes D, Pawelek J. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis. 1998;16:299-312. [PMID: 9626809 DOI: 10.1023/a:1006557228604] [Cited by in Crossref: 85] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
95 Kiyokawa H, Richon VM, Rifkind RA, Marks PA. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 1994;14:7195-203. [PMID: 7935434 DOI: 10.1128/mcb.14.11.7195-7203.1994] [Cited by in Crossref: 66] [Article Influence: 2.4] [Reference Citation Analysis]
96 Kong XT, Choi SH, Inoue A, Takita J, Yokota J, Hanada R, Yamamoto K, Bessho F, Yanagisawa M, Hayashi Y. Alterations of the tumour suppressor gene DCC in neuroblastoma. Eur J Cancer 1997;33:1962-5. [PMID: 9516833 DOI: 10.1016/s0959-8049(97)00209-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
97 Shannon K. Genetic predispositions and childhood cancer. Environ Health Perspect 1998;106 Suppl 3:801-6. [PMID: 9646040 DOI: 10.1289/ehp.98106801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
98 Vanacker JM, Laudet V, Adelmant G, Stéhelin D, Rommelaere J. Interconnection between thyroid hormone signalling pathways and parvovirus cytotoxic functions. J Virol 1993;67:7668-72. [DOI: 10.1128/jvi.67.12.7668-7672.1993] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
99 Shaulian E, Zauberman A, Ginsberg D, Oren M. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 1992;12:5581-92. [PMID: 1448088 DOI: 10.1128/mcb.12.12.5581-5592.1992] [Cited by in Crossref: 213] [Article Influence: 7.3] [Reference Citation Analysis]
100 Dall'olio F, Malagolini N, Guerrini S, Lau JTY, Serafini-cessi F. Differentiation-dependent expression of human?-galactoside?2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells. Glycoconjugate J 1996;13:115-21. [DOI: 10.1007/bf01049687] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
101 European Food Safety Authority (EFSA). Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances Which are both Genotoxic and Carcinogenic: Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances Which are both Genotoxic. EFSA Journal 2005;3:282. [DOI: 10.2903/j.efsa.2005.282] [Cited by in Crossref: 132] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
102 Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology. 1995;109:1685-1699. [PMID: 7557155 DOI: 10.1016/0016-5085(95)90660-6] [Cited by in Crossref: 114] [Cited by in F6Publishing: 100] [Article Influence: 4.4] [Reference Citation Analysis]
103 Berney CR, Fisher RJ, Yang J, Russell PJ, Crowe PJ. Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer 2000;89:1-7. [DOI: 10.1002/(sici)1097-0215(20000120)89:1<1::aid-ijc1>3.0.co;2-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
104 Moses HL. TGF-? regulation of epithelial cell proliferation. Mol Reprod Dev 1992;32:179-84. [DOI: 10.1002/mrd.1080320215] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
105 Chin D, Boyle GM, Theile DR, Parsons PG, Coman WB. Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. British Journal of Plastic Surgery 2004;57:595-602. [DOI: 10.1016/j.bjps.2004.06.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
106 Nowak MA, Michor F, Komarova NL, Iwasa Y. Evolutionary dynamics of tumor suppressor gene inactivation. Proc Natl Acad Sci U S A 2004;101:10635-8. [PMID: 15252197 DOI: 10.1073/pnas.0400747101] [Cited by in Crossref: 74] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
107 Yagui-Beltrán A, He B, Raz D, Kim J, Jablons DM. Novel therapies targeting signaling pathways in lung cancer. Thorac Surg Clin 2006;16:379-96, vi. [PMID: 17240825 DOI: 10.1016/j.thorsurg.2006.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
108 Israel K, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways. Nutr Cancer. 1995;24:161-169. [PMID: 8584452 DOI: 10.1080/01635589509514404] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 2.8] [Reference Citation Analysis]
109 Reinartz JJ. Cancer Genes. In: Coleman WB, Tsongalis GJ, editors. The Molecular Basis of Human Cancer. Totowa: Humana Press; 2002. pp. 45-64. [DOI: 10.1007/978-1-59259-125-1_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
110 Friedmann T. Gene therapy — a new kind of medicine. Trends in Biotechnology 1993;11:156-9. [DOI: 10.1016/0167-7799(93)90106-j] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
111 Pavelić K, Dedivitis RA, Kapitanović S, Čačev T, Guirado CR, Danić D, Radošević S, Brkić K, Pegan B, Križanac Š, Kusić Z, Spaventi Š, Bura M. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2006;599:45-57. [DOI: 10.1016/j.mrfmmm.2006.01.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
112 Peeper DS, Bernards R. Communication between the extracellular environment, cytoplasmic signalling cascades and the nuclear cell-cycle machinery. FEBS Lett 1997;410:11-6. [PMID: 9247113 DOI: 10.1016/s0014-5793(97)00319-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
113 Johnson MD, Jennings MT, Gold LI, Moses HL. Transforming growth factor-beta in neural embryogenesis and neoplasia. Hum Pathol 1993;24:457-62. [PMID: 8387957 DOI: 10.1016/0046-8177(93)90156-b] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
114 Lindblad-toh K, Tanenbaum DM, Daly MJ, Winchester E, Lui W, Villapakkam A, Stanton SE, Larsson C, Hudson TJ, Johnson BE, Lander ES, Meyerson M. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 2000;18:1001-5. [DOI: 10.1038/79269] [Cited by in Crossref: 186] [Cited by in F6Publishing: 160] [Article Influence: 8.9] [Reference Citation Analysis]
115 Karameris AM, Worthy E, Gorgoulis VG, Quezado M, Anastassiades OT. p53 gene alterations in special types of breast carcinoma: A molecular and immunohistochemical study in archival material. J Pathol 1995;176:361-72. [DOI: 10.1002/path.1711760407] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
116 Kouzarides T. Transcriptional regulation by the retinoblastoma protein. Trends Cell Biol 1993;3:211-3. [PMID: 14731754 DOI: 10.1016/0962-8924(93)90113-f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
117 Weinberg R. Tumor suppressor genes. Neuron 1993;11:191-6. [PMID: 8352939 DOI: 10.1016/0896-6273(93)90177-s] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
118 Peinado MA, Malkhosyan S, Velazquez A, Perucho M. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci U S A 1992;89:10065-9. [PMID: 1359533 DOI: 10.1073/pnas.89.21.10065] [Cited by in Crossref: 159] [Cited by in F6Publishing: 143] [Article Influence: 5.5] [Reference Citation Analysis]
119 Hahn SA, Kern SE. Molecular Genetics of Exocrine Pancreatic Neoplasms. Surgical Clinics of North America 1995;75:857-69. [DOI: 10.1016/s0039-6109(16)46732-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
120 Wadhwa R, Kaul S, Ikawa Y, Sugimoto Y. Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. Journal of Biological Chemistry 1993;268:6615-21. [DOI: 10.1016/s0021-9258(18)53295-6] [Cited by in Crossref: 86] [Article Influence: 3.1] [Reference Citation Analysis]
121 Shen C, Zhou Y, Zhan J, Reske SN, Buck AK. Chromosome instability and tumor lethality suppression in carcinogenesis. J Cell Biochem 2008;105:1327-41. [DOI: 10.1002/jcb.21937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
122 Nagpal JK, Das BR. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncology 2003;39:213-21. [DOI: 10.1016/s1368-8375(02)00162-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
123 Kitagawa T, Tsuruhara Y, Hayashi M, Endo T, Stanbridge E. A tumor-associated glycosylation change in the glucose transporter GLUT1 controlled by tumor suppressor function in human cell hybrids. Journal of Cell Science 1995;108:3735-43. [DOI: 10.1242/jcs.108.12.3735] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
124 Akiyama T, Ohuchi T, Sumida S, Matsumoto K, Toyoshima K. Phosphorylation of the retinoblastoma protein by cdk2. Proc Natl Acad Sci U S A 1992;89:7900-4. [PMID: 1518810 DOI: 10.1073/pnas.89.17.7900] [Cited by in Crossref: 145] [Cited by in F6Publishing: 138] [Article Influence: 5.0] [Reference Citation Analysis]
125 Schwartsmann G, Workman P. Anticancer drug screening and discovery in the 1990s: a European perspective. European Journal of Cancer 1993;29:3-14. [DOI: 10.1016/0959-8049(93)90567-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 1998;17:6888-902. [PMID: 9843495 DOI: 10.1093/emboj/17.23.6888] [Cited by in Crossref: 251] [Cited by in F6Publishing: 252] [Article Influence: 11.4] [Reference Citation Analysis]
127 Jacobson EL, Jacobson MK. A biomarker for the assessment of niacin nutriture as a potential preventive factor in carcinogenesis. J Intern Med 1993;233:59-62. [PMID: 8429288 DOI: 10.1111/j.1365-2796.1993.tb00649.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
128 Lee C. Cellular interactions in prostate cancer. British Journal of Urology 1997;79:21-7. [DOI: 10.1111/j.1464-410x.1997.tb00797.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
129 Yin Z, Spitz MR, Babaian RJ, Strom SS, Troncoso P, Kagan J. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 1999;18:7576-83. [DOI: 10.1038/sj.onc.1203203] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
130 Ding SF, Delhanty JD, Bowles L, Dooley JS, Wood CB, Habib NA. Infrequent chromosome allele loss in fibrolamellar carcinoma. Br J Cancer 1993;67:244-6. [PMID: 8094289 DOI: 10.1038/bjc.1993.47] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
131 Vielmetter J, Kayyem JF, Roman JM, Dreyer WJ. Neogenin, an avian cell surface protein expressed during terminal neuronal differentiation, is closely related to the human tumor suppressor molecule deleted in colorectal cancer. J Cell Biol 1994;127:2009-20. [PMID: 7806578 DOI: 10.1083/jcb.127.6.2009] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 4.5] [Reference Citation Analysis]
132 Macgregor D, Li L, Ziff EB. Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1a with Ras. J Cell Physiol 1996;167:95-105. [DOI: 10.1002/(sici)1097-4652(199604)167:1<95::aid-jcp11>3.0.co;2-o] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
133 Fan H. Retroviruses and Their Role in Cancer. In: Levy JA, editor. The Retroviridae. Boston: Springer US; 1994. pp. 313-62. [DOI: 10.1007/978-1-4899-1730-0_7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
134 Dahiya R, Mccarville J, Hu W, Lee C, Chui RM, Kaur G, Deng G. Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. Int J Cancer 1997;71:20-5. [DOI: 10.1002/(sici)1097-0215(19970328)71:1<20::aid-ijc5>3.0.co;2-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
135 Arai K, Shibahara T, Yamamoto N, Noma H. The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas. Oral Oncology 2002;38:763-71. [DOI: 10.1016/s1368-8375(02)00068-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
136 Tamura K, Umemura S, Nyui N, Yamaguchi S, Ishigami T, Hibi K, Yabana M, Kihara M, Fukamizu A, Murakami K, Ishii M. A Novel Proximal Element Mediates the Regulation of Mouse Ren-1C Promoter by Retinoblastoma Protein in Cultured Cells. Journal of Biological Chemistry 1997;272:16845-51. [DOI: 10.1074/jbc.272.27.16845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
137 Kissane JM, Dehner LP. Renal tumors and tumor-like lesions in pediatric patients. Pediatr Nephrol 1992;6:365-82. [DOI: 10.1007/bf00869741] [Cited by in Crossref: 22] [Article Influence: 0.8] [Reference Citation Analysis]
138 Garcia JM, Garcia V, Silva J, Peña C, Dominguez G, Sanchez A, Sanfrutos L, Provencio M, Millan I, Chaparro D, España P, Bonilla F. Extracellular tumor DNA in plasma and overall survival in breast cancer patients. Genes Chromosomes Cancer 2006;45:692-701. [PMID: 16607614 DOI: 10.1002/gcc.20334] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
139 Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993;13:4976-85. [PMID: 8336730 DOI: 10.1128/mcb.13.8.4976-4985.1993] [Cited by in Crossref: 412] [Article Influence: 14.7] [Reference Citation Analysis]
140 Erlanson DA, Verdine GL. Falling out of the fold: tumorigenic mutations and p53. Chem Biol 1994;1:79-84. [PMID: 9383374 DOI: 10.1016/1074-5521(94)90044-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
141 Sandgren EP, Palmiter RD, Heckel JL, Brinster RL, Degen JL. DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice. Proc Natl Acad Sci U S A 1992;89:11523-7. [PMID: 1454842 DOI: 10.1073/pnas.89.23.11523] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
142 Amsler U, Pasi A, Qu B. A novel hypothesis: Specific oncogenes and tumor suppression genes are involved in the expression of the proopiomelanocortin gene by small cell lung cancer. Medical Hypotheses 1994;42:397-9. [DOI: 10.1016/0306-9877(94)90162-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Leung K, Pedlar J, High A. Decreasing p53 overexpression in sequential, recurrent, oral squamous cell carcinomas. British Journal of Oral and Maxillofacial Surgery 1996;34:225-9. [DOI: 10.1016/s0266-4356(96)90274-0] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
144 Liao PH, Chang YC, Huang MF, Tai KW, Chou MY. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol 2000;36:272-6. [PMID: 10793330 DOI: 10.1016/s1368-8375(00)00005-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
145 Liu P, Zhang H, Mclellan A, Vogel H, Bradley A. Embryonic Lethality and Tumorigenesis Caused by Segmental Aneuploidy on Mouse Chromosome 11. Genetics 1998;150:1155-68. [DOI: 10.1093/genetics/150.3.1155] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.9] [Reference Citation Analysis]
146 Wu X, Merup M, Juliusson G, Jansson M, Stellan B, Grandér D, Zabarovsky E, Liu Y, Spasokoukotskaja T, Gahrton G, Einhorn S. Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint. Genes Chromosom Cancer 1997;20:337-46. [DOI: 10.1002/(sici)1098-2264(199712)20:4<337::aid-gcc4>3.0.co;2-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
147 Simmons-Menchaca M, Qian M, Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells. Nutr Cancer. 1995;24:171-185. [PMID: 8584453 DOI: 10.1080/01635589509514405] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
148 Abdollahi A, Bao R, Hamilton TC. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene 1999;18:6477-87. [DOI: 10.1038/sj.onc.1203067] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
149 Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 1993;73:487-497. [PMID: 8343202 DOI: 10.1016/0092-8674(93)90136-e] [Cited by in Crossref: 667] [Cited by in F6Publishing: 268] [Article Influence: 23.8] [Reference Citation Analysis]
150 Felder CC, MacArthur L, Ma AL, Gusovsky F, Kohn EC. Tumor-suppressor function of muscarinic acetylcholine receptors is associated with activation of receptor-operated calcium influx. Proc Natl Acad Sci U S A 1993;90:1706-10. [PMID: 7680475 DOI: 10.1073/pnas.90.5.1706] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
151 Salnikow K, Cosentino S, Klein C, Costa M. Loss of thrombospondin transcriptional activity in nickel-transformed cells. Mol Cell Biol 1994;14:851-8. [PMID: 8264652 DOI: 10.1128/mcb.14.1.851-858.1994] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
152 Berchuck A, Elbendary A, Havrilesky L, Rodriguez GC, Bast RC Jr. Pathogenesis of ovarian cancers. J Soc Gynecol Investig 1994;1:181-90. [PMID: 9419769 DOI: 10.1177/107155769400100302] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
153 Sun Y, Nakamura K, Hegamyer G, Dong Z, Colburn N. No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Mol Carcinog 1993;8:49-57. [PMID: 8352891 DOI: 10.1002/mc.2940080111] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
154 Ko S, Na Y, Yoon C, Park J, Kim H, Hur M, Lee H, Chun Y, Kang S, Park B, Lee J. The Significance of c-erbB-2 Overexpression and p53 Expression in Patients With Axillary Lymph Node—Negative Breast Cancer: A Tissue Microarray Study. Int J Surg Pathol 2007;15:98-109. [DOI: 10.1177/1066896906299124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
155 Tian G, Liu J, Zhou JS, Chen W. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial. Anticancer Drugs. 2009;20:389-395. [PMID: 19287305 DOI: 10.1097/CAD.0b013e32832a2df9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
156 Linares-Cruz G, Bruzzoni-Giovanelli H, Alvaro V, Roperch JP, Tuynder M, Schoevaert D, Nemani M, Prieur S, Lethrosne F, Piouffre L, Reclar V, Faille A, Chassoux D, Dausset J, Amson RB, Calvo F, Telerman A. p21WAF-1 reorganizes the nucleus in tumor suppression. Proc Natl Acad Sci U S A 1998;95:1131-5. [PMID: 9448297 DOI: 10.1073/pnas.95.3.1131] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 1.9] [Reference Citation Analysis]
157 Knuutila S, Aalto Y, Autio K, Björkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M, Zhu Y. DNA copy number losses in human neoplasms. Am J Pathol 1999;155:683-94. [PMID: 10487825 DOI: 10.1016/S0002-9440(10)65166-8] [Cited by in Crossref: 270] [Cited by in F6Publishing: 77] [Article Influence: 12.3] [Reference Citation Analysis]
158 Hamilton SR. Molecular genetics of colorectal carcinoma. Cancer 1992;70:1216-21. [PMID: 1511369 DOI: 10.1002/1097-0142(19920901)70:3+<1216::aid-cncr2820701505>3.0.co;2-f] [Cited by in Crossref: 57] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
159 Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RM, Williams AW, Steel CM, Bird CC. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci U S A 1994;91:6953-7. [PMID: 8041728 DOI: 10.1073/pnas.91.15.6953] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 3.3] [Reference Citation Analysis]
160 Corn PG, El-deiry WS. Derangement of growth and differentiation control in oncogenesis. Bioessays 2002;24:83-90. [DOI: 10.1002/bies.10036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
161 Sherratt T, Morelli C, Boyle JM, Harrison CJ. Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21. Chromosome Res 1997;5:118-24. [PMID: 9146915 DOI: 10.1023/a:1018418224660] [Cited by in Crossref: 30] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
162 Gabrielli F, Donadel G, Bensi G, Heguy A, Melli M. A nuclear protein, synthesized in growth-arrested human hepatoblastoma cells, is a novel member of the short-chain alcohol dehydrogenase family. Eur J Biochem 1995;232:473-7. [PMID: 7556196 DOI: 10.1111/j.1432-1033.1995.473zz.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
163 Cheng TM, Coffey RJ, Gelber BR, Scheithauer BW. Simultaneous presentation of symptomatic subependymomas in siblings: case reports and review. Neurosurgery 1993;33:145-50. [PMID: 8355833 DOI: 10.1227/00006123-199307000-00025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
164 Arenas RB, Fichera A, Mok P, Blanco MC, Michelassi F. Introduction of human adenomatous polyposis coli gene into Min mice via cationic liposomes. Surgery 1996;120:712-8. [DOI: 10.1016/s0039-6060(96)80021-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
165 Paggi MG, Baldi A, Bonetto F, Giordano A. Retinoblastoma protein family in cell cycle and cancer: A review. J Cell Biochem 1996;62:418-30. [DOI: 10.1002/(sici)1097-4644(199609)62:3<418::aid-jcb12>3.0.co;2-e] [Cited by in Crossref: 127] [Article Influence: 5.1] [Reference Citation Analysis]
166 Smyth MJ, Sparks RL, Wharton W. Proadipocyte cell lines: models of cellular proliferation and differentiation. Journal of Cell Science 1993;106:1-9. [DOI: 10.1242/jcs.106.1.1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
167 He B, Jablons DM. Wnt signaling in stem cells and lung cancer. Ernst Schering Found Symp Proc 2006;:27-58. [PMID: 17939294 DOI: 10.1007/2789_2007_043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
168 Randerath K, Randerath E. 32P-postlabeling methods for DNA adduct detection: overview and critical evaluation. Drug Metab Rev 1994;26:67-85. [PMID: 8082582 DOI: 10.3109/03602539409029785] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 2.9] [Reference Citation Analysis]
169 Cocks B, Vairo G, Bodrug S, Hamilton J. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. Journal of Biological Chemistry 1992;267:12307-10. [DOI: 10.1016/s0021-9258(19)49839-6] [Cited by in Crossref: 41] [Article Influence: 1.4] [Reference Citation Analysis]
170 Munier FL, Thonney F, Balmer A, Uffer S, Héon E, Melle GV, Rutz HP, Pescia G, Schorderet DF. Prognostic factors associated with loss of heterozygosity at the RB1 locus in retinoblastoma. Ophthalmic Genetics 2009;18:7-12. [DOI: 10.3109/13816819709057878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
171 Friedmann T. Approaches to Gene Therapy of Complex Multigenic Diseases: Cancer as a Model and Implications for Cardiovascular Disease and Diabetes. Annals of Medicine 2009;24:411-7. [DOI: 10.3109/07853899209147847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
172 van Elsas A, Zerp S, van der Flier S, Krüse-wolters M, Vacca A, Ruiter DJ, Schrier P. Analysis of N-ras Mutations in Human Cutaneous Melanoma: Tumor Heterogeneity Detected by Polymerase Chain Reaction/Single-Stranded Conformation Polymorphism Analysis. In: Garbe C, Schmitz S, Orfanos CE, editors. Skin Cancer: Basic Science, Clinical Research and Treatment. Berlin: Springer Berlin Heidelberg; 1995. pp. 57-67. [DOI: 10.1007/978-3-642-78771-3_5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
173 Fischer M, Müller GA. Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes. Crit Rev Biochem Mol Biol 2017;52:638-62. [PMID: 28799433 DOI: 10.1080/10409238.2017.1360836] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 21.8] [Reference Citation Analysis]
174 Ghebranious N, Sell S. The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice. Hepatology 1998;27:967-73. [DOI: 10.1002/hep.510270411] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
175 Piao Z, Park C, Park J, Kim H. Deletion mapping of chromosome 4q in hepatocellular carcinoma. Int J Cancer 1998;79:356-60. [DOI: 10.1002/(sici)1097-0215(19980821)79:4<356::aid-ijc8>3.0.co;2-u] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
176 Okumoto M, Park Y, Song C, Mori N. Frequent loss of heterozygosity on chromosomes 4, 12 and 19 in radiation-induced lymphomas in mice. Cancer Letters 1999;135:223-8. [DOI: 10.1016/s0304-3835(98)00305-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
177 Semenza JC, Weasel LH. Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ Health Perspect 1997;105 Suppl 1:155-63. [PMID: 9114284 DOI: 10.1289/ehp.97105s1155] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
178 Ding S, Habib NA. Loss of heterozygosity in liver tumours. Journal of Hepatology 1995;22:230-8. [DOI: 10.1016/0168-8278(95)80434-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
179 Smith RC, Rukstalis DB. Frequent Loss of Heterozygosity at 11p Loci in Testicular Cancer. Journal of Urology 1995;153:1684-7. [DOI: 10.1016/s0022-5347(01)67504-9] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
180 Ponder BA. Cancer genetics. Nature. 2001;411:336-341. [PMID: 11357140 DOI: 10.1038/35077207] [Cited by in Crossref: 361] [Cited by in F6Publishing: 264] [Article Influence: 18.1] [Reference Citation Analysis]
181 Lundberg A, Weinberg R. Control of the cell cycle and apoptosis. European Journal of Cancer 1999;35:1886-94. [DOI: 10.1016/s0959-8049(99)00292-0] [Cited by in Crossref: 159] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
182 Guo Z, Li Q, Wilander E, Pont�n J. Clonality analysis of multifocal carcinoid tumours of the small intestine by X-chromosome inactivation analysis. J Pathol 2000;190:76-9. [DOI: 10.1002/(sici)1096-9896(200001)190:1<76::aid-path499>3.0.co;2-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
183 Cox R. Molecular Mechanisms of Radiation Oncogenesis. International Journal of Radiation Biology 2009;65:57-64. [DOI: 10.1080/09553009414550081] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
184 Negraes PD, Favaro FP, Camargo JL, Oliveira ML, Goldberg J, Rainho CA, Salvadori DM. DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection. BMC Cancer. 2008;8:238. [PMID: 18702824 DOI: 10.1186/1471-2407-8-238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
185 Johnson TC. Negative regulators of cell proliferation. Pharmacol Ther. 1994;62:247-265. [PMID: 7991645 DOI: 10.1016/0163-7258(94)90013-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
186 Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF. Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 1995;82:733-42. [DOI: 10.1016/0092-8674(95)90470-0] [Cited by in Crossref: 104] [Cited by in F6Publishing: 111] [Article Influence: 4.0] [Reference Citation Analysis]
187 Li F, Garber J. CANCER GENETICS. The Lancet 1993;341:1060-1. [DOI: 10.1016/0140-6736(93)92416-q] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
188 Park KK, Deok Ahn J, Lee IK, Magae J, Heintz NH, Kwak JY, Lee YC, Cho YS, Kim HC, Chae YM, Ho Kim Y, Kim CH, Chang YC. Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexpression of E2F/DP. Biochem Biophys Res Commun 2003;308:689-97. [PMID: 12927774 DOI: 10.1016/s0006-291x(03)01455-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
189 Ghebranious N, Sell S. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. Hepatology. 1998;27:383-391. [PMID: 9462635 DOI: 10.1002/hep.510270211] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 2.6] [Reference Citation Analysis]
190 Tanner DC, Cherry JD, Mayer-Pröschel M. Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-γ. J Neurosci 2011;31:6235-46. [PMID: 21508246 DOI: 10.1523/JNEUROSCI.5905-10.2011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
191 Gerharz CD, Ramp U, Olert J, Moll R, Störkel S, Marx N, Gabbert HE. Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type. Virchows Arch 1994;424:403-9. [PMID: 7515757 DOI: 10.1007/BF00190563] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
192 Inoue A, Torigoe T, Sogahata K, Kamiguchi K, Takahashi S, Sawada Y, Saijo M, Taya Y, Ishii S, Sato N, Kikuchi K. 70-kDa Heat Shock Cognate Protein Interacts Directly with the N-terminal Region of the Retinoblastoma Gene Product pRb. Journal of Biological Chemistry 1995;270:22571-6. [DOI: 10.1074/jbc.270.38.22571] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
193 Wang Y, Zhang S, Zhang C, Zhao Z, Zheng X, Xue L, Liu J, Yuan X. Investigation of an SPR biosensor for determining the influence of connexin 43 expression on the cytotoxicity of cisplatin. Analyst 2016;141:3411-20. [DOI: 10.1039/c6an00264a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
194 Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease. Head Neck 2001;23:238-53. [DOI: 10.1002/1097-0347(200103)23:3<238::aid-hed1025>3.0.co;2-h] [Cited by in Crossref: 139] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
195 Hsu Y, Shaw C. Expression of p53, DCC, and HER-2/neu in Mucinous Carcinoma of the Breast. The Kaohsiung Journal of Medical Sciences 2005;21:197-202. [DOI: 10.1016/s1607-551x(09)70188-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
196 Workman P. Signal transduction inhibitors as novel anticancer drugs: Where are we? Annals of Oncology 1992;3:527-31. [DOI: 10.1093/oxfordjournals.annonc.a058253] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
197 Danesi DT, Spanò M, Antonini F, Altavista P, Catalano P, Cordelli E, Pasqualetti P, Santacroce C, Toscano MG, Mecozzi A, Fabiano A. Flow Cytometric and Immunohistochemical Correlations in High Incidence Human Solid Tumors. Tumori 1997;83:689-97. [DOI: 10.1177/030089169708300313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Jeoung DI, Tang B, Sonenberg M. Effects of tumor necrosis factor-alpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J Biol Chem 1995;270:18367-73. [PMID: 7629160 DOI: 10.1074/jbc.270.31.18367] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 2.1] [Reference Citation Analysis]
199 Kang SM, Lee HJ. MicroRNAs in human lung cancer. Exp Biol Med (Maywood) 2014;239:1505-13. [PMID: 24872439 DOI: 10.1177/1535370214533887] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
200 Wu Y, Zhou H, Duesberg P. Unmutated proto-src coding region is tumorigenic if expressed from the promoter of Rous sarcoma virus: implications for the gene-mutation hypothesis of cancer. Proc Natl Acad Sci U S A 1992;89:6393-7. [PMID: 1321438 DOI: 10.1073/pnas.89.14.6393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
201 King TJ, Bertram JS. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta 2005;1719:146-60. [PMID: 16263076 DOI: 10.1016/j.bbamem.2005.08.012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
202 Kim JW, Cho YH, Lee CG, Kim JH, Kim HK, Kim EJ, Han KT, Namkoong SE. Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma. Acta Oncol 1997;36:295-300. [PMID: 9208900 DOI: 10.3109/02841869709001266] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
203 Mori N, Morosetti R, Spira S, Lee S, Ben-yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP. Chromosome Band 1p36 Contains a Putative Tumor Suppressor Gene Important in the Evolution of Chronic Myelocytic Leukemia. Blood 1998;92:3405-9. [DOI: 10.1182/blood.v92.9.3405.421k44_3405_3409] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
204 Dreyling M, Kobayashi H, Olopade O, Le Beau M, Rowley J, Bohlander S. Detection of 9p deletions in leukemia cell lines by interphase fluorescence in situ hybridization with YAC-derived probes. Cancer Genetics and Cytogenetics 1995;83:46-55. [DOI: 10.1016/s0165-4608(95)00026-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
205 Pagnano KB, Vassallo J, Lorand-metze I, Costa FF, Saad ST. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas. Am J Hematol 2001;67:84-92. [DOI: 10.1002/ajh.1084] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
206 Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-oliveira M, Martel-planche G, Goldim JR, Hainaut P, Camey SA, Ashton-prolla P. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil: Li-Fraumeni Syndrome in Pediatric Cancer. Cancer 2013;119:4341-9. [DOI: 10.1002/cncr.28346] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
207 Hacker SM, Mortensen F, Scheffner M, Marx A. Selektive Beobachtung der enzymatischen Aktivität des Tumorsuppressors Fhit. Angew Chem 2014;126:10413-6. [DOI: 10.1002/ange.201405259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
208 Paggi MG, Baldi A, Bonetto F, Giordano A. Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem 1996;62:418-30. [PMID: 8872613 DOI: 10.1002/(SICI)1097-4644(199609)62:3%3C418::AID-JCB12%3E3.0.CO;2-E] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
209 Merlo GR, Bernardi A, Diella F, Venesio T, Cappa AP, Callahan R, Liscia DS. In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index. Int J Cancer 1993;54:531-5. [PMID: 8514444 DOI: 10.1002/ijc.2910540402] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
210 Ohta M, Nitta M, Yamaizumi M. High sensitivity of the ultraviolet-induced p53 response in ultraviolet-sensitive syndrome, a photosensitive disorder with a putative defect in deoxyribonucleic acid repair of actively transcribed genes. Mutat Res 1999;433:23-32. [PMID: 10047776 DOI: 10.1016/s0921-8777(98)00058-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
211 Kumar TR, Donehower LA, Bradley A, Matzuk MM. Transgenic mouse models for tumour-suppressor genes. Journal of Internal Medicine 1995;238:233-8. [DOI: 10.1111/j.1365-2796.1995.tb00928.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
212 Mendes RA, Carvalho JF, Waal IVD. Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment – An overview. Oral Oncology 2010;46:19-24. [DOI: 10.1016/j.oraloncology.2009.10.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
213 Semczuk A, Jakowicki JA. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. Cancer Lett 2004;203:1-12. [PMID: 14670612 DOI: 10.1016/j.canlet.2003.09.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
214 Sirchia SM, Sironi E, Grati FR, Serafini P, Garagiola I, Rossella F, Dulcetti F, Pardi G, Garsia S, Simoni G. Losses of Heterozygosity in Endometrial Adenocarcinomas. Cancer Genetics and Cytogenetics 2000;121:156-62. [DOI: 10.1016/s0165-4608(00)00240-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
215 Taniura H, Taniguchi N, Hara M, Yoshikawa K. Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1. J Biol Chem. 1998;273:720-728. [PMID: 9422723 DOI: 10.1074/jbc.273.2.720] [Cited by in Crossref: 117] [Cited by in F6Publishing: 122] [Article Influence: 5.1] [Reference Citation Analysis]
216 Fattman CL, Delach SM, Dou QP, Johnson DE. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene 2001;20:2918-26. [PMID: 11420704 DOI: 10.1038/sj.onc.1204414] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
217 Traver D, Akashi K, Weissman IL, Lagasse E. Mice Defective in Two Apoptosis Pathways in the Myeloid Lineage Develop Acute Myeloblastic Leukemia. Immunity 1998;9:47-57. [DOI: 10.1016/s1074-7613(00)80587-7] [Cited by in Crossref: 120] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
218 Johnson DG, Cress WD, Jakoi L, Nevins JR. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A 1994;91:12823-7. [PMID: 7809128 DOI: 10.1073/pnas.91.26.12823] [Cited by in Crossref: 159] [Cited by in F6Publishing: 170] [Article Influence: 6.1] [Reference Citation Analysis]
219 Zhou W, Takuwa N, Kumada M, Takuwa Y. Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. Journal of Biological Chemistry 1993;268:23041-8. [DOI: 10.1016/s0021-9258(19)49422-2] [Cited by in Crossref: 61] [Article Influence: 2.2] [Reference Citation Analysis]
220 Jia L, Wang XW, Sun Z, Harris CC. Interactive Effects of p53 Tumor Suppressor Gene and Hepatitis B Virus in Hepatocellular Carcinogenesis. In: Tahara E, editor. Molecular Pathology of Gastroenterological Cancer. Tokyo: Springer Japan; 1997. pp. 209-18. [DOI: 10.1007/978-4-431-65915-0_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
221 Liu Y, Heyman M, Wang Y, Falkmer U, Hising C, Székely L, Einhorn S. Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells. Int J Cancer 1994;58:663-7. [PMID: 8077050 DOI: 10.1002/ijc.2910580508] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
222 Crowell RE, Belinsky SA. Genetic changes in lung cancer: Potential biomarkers for early detection and prevention. Journal of Laboratory and Clinical Medicine 1997;130:550-7. [DOI: 10.1016/s0022-2143(97)90104-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
223 Ishibashi M, Kogo R, Shibata K, Ueo H, Uchi R, Matsumura T, Takano Y, Sawada G, Takahashi Y, Mima K, Kurashige J, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Suzuki A, Wakabayashi G, Mori M, Mimori K. Clinical Significance of PICT1 in Patients of Hepatocellular Carcinoma with Wild-Type TP53. Ann Surg Oncol 2013;20:537-44. [DOI: 10.1245/s10434-013-2958-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
224 Kim TE, Kim YW, Hwang SY, Shin SM, Shin JW, Lee YH, Shin SY, Han KT, Lee JM, Namkoong SE, Kim JW. Candidate tumor suppressor, HCCS-1, is downregulated in human cancers and induces apoptosis in cervical cancer. Int J Cancer 2002;97:780-6. [DOI: 10.1002/ijc.10124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
225 White R. Inherited cancer genes. Current Opinion in Genetics & Development 1992;2:53-7. [DOI: 10.1016/s0959-437x(05)80321-1] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
226 Thapar K, Kovacs K, Laws ER. The classification and molecular biology of pituitary adenomas. Adv Tech Stand Neurosurg 1995;22:3-53. [PMID: 7495421 DOI: 10.1007/978-3-7091-6898-1_1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
227 Wang LQ, Liang R, Chim CS. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies. Expert Rev Mol Diagn 2012;12:755-65. [PMID: 23153241 DOI: 10.1586/erm.12.64] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
228 Mori N, Yoshinaga K, Tomita K, Ohwashi M, Kondoh T, Shimura H, Wang YH, Shiseki M, Okada M, Motoji T. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia. Leuk Res 2011;35:516-21. [PMID: 20828818 DOI: 10.1016/j.leukres.2010.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
229 Leon SP, Zhu J, Black PM. Genetic Aberrations in Human Brain Tumors. Neurosurgery 1994;34:708-22. [DOI: 10.1097/00006123-199404000-00021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
230 Klein KG, Bouck NP. The distal region of the long arm of human chromosome 1 carries tumor suppressor activity for a human fibrosarcoma line. Cancer Genetics and Cytogenetics 1994;73:109-21. [DOI: 10.1016/0165-4608(94)90194-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
231 Kato H, Arakawa A, Suzumori K, Kataoka N, Young SR. FISH analysis of BRCA1 copy number in paraffin-embedded ovarian cancer tissue samples. Exp Mol Pathol 2004;76:138-42. [PMID: 15010292 DOI: 10.1016/j.yexmp.2003.11.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
232 Kihana T, Hamada K, Inoue Y, Yano N, Iketani H, Murao S, Ukita M, Matsuura S. Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients. Cancer 1995;76:72-8. [DOI: 10.1002/1097-0142(19950701)76:1<72::aid-cncr2820760110>3.0.co;2-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
233 Oʼmarcaigh AS, Shannon KM. Role of the NF1 Gene in Leukemogenesis and Myeloid Growth Control: . Journal of Pediatric Hematology/Oncology 1997;19:551-4. [DOI: 10.1097/00043426-199711000-00015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
234 Powers S, Pollack RE. Inducing stable reversion to achieve cancer control. Nat Rev Cancer 2016;16:266-70. [DOI: 10.1038/nrc.2016.12] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
235 Rodriguez-Puebla ML, LaCava M, Miliani De Marval PL, Jorcano JL, Richie ER, Conti CJ. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia. Am J Pathol 2000;157:1039-50. [PMID: 10980142 DOI: 10.1016/S0002-9440(10)64616-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
236 Huang CY, Zhao JJ, Lv L, Chen YB, Li YF, Jiang SS, Wang W, Pan K, Zheng Y, Zhao BW, Wang DD, Chen YM, Yang L, Zhou ZW, Xia JC. Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancer. PLoS One 2013;8:e69155. [PMID: 23935945 DOI: 10.1371/journal.pone.0069155] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
237 Zhai Y, Wirth J, Kang S, Welsch CW, Esselman WJ. LAR-PTPase cDNA transfection suppression of tumor growth ofneu oncogene-transformed human breast carcinoma cells. Mol Carcinog 1995;14:103-10. [DOI: 10.1002/mc.2940140206] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
238 Callahan R, Cropp C, Merlo GR, Diella F, Venesio T, Lidereau R, Cappa AP, Lisicia DS. Genetic and molecular heterogeneity of breast cancer cells. Clinica Chimica Acta 1993;217:63-73. [DOI: 10.1016/0009-8981(93)90238-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
239 Ayer DE, Kretzner L, Eisenman RN. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 1993;72:211-22. [PMID: 8425218 DOI: 10.1016/0092-8674(93)90661-9] [Cited by in Crossref: 473] [Cited by in F6Publishing: 493] [Article Influence: 16.9] [Reference Citation Analysis]
240 Bookstein R, Allred DC. Recessive oncogenes. Cancer 1993;71:1179-86. [DOI: 10.1002/1097-0142(19930201)71:3+<1179::aid-cncr2820711442>3.0.co;2-b] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
241 Niwa S, Ueno S, Shirasu R. Alteration of pRb expression in the development of rat tongue carcinoma induced by 4-nitroquinoline 1-oxide. Oral Oncology 2001;37:579-85. [DOI: 10.1016/s1368-8375(00)00141-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
242 Xu J, Gimenez-conti IB, Cunningham JE, Collet AM, Luna MA, Lanfranchi HE, Spitz MR, Conti CJ. Alterations of p53, cyclin D1, rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998;83:204-12. [DOI: 10.1002/(sici)1097-0142(19980715)83:2<204::aid-cncr2>3.0.co;2-q] [Cited by in Crossref: 69] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
243 Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 1993;74:1009-20. [DOI: 10.1016/0092-8674(93)90723-4] [Cited by in Crossref: 362] [Cited by in F6Publishing: 345] [Article Influence: 12.9] [Reference Citation Analysis]
244 Brachova P, Thiel KW, Leslie KK. The consequence of oncomorphic TP53 mutations in ovarian cancer. Int J Mol Sci 2013;14:19257-75. [PMID: 24065105 DOI: 10.3390/ijms140919257] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
245 Dirks PB, Rutka JT. Current Concepts in Neuro-Oncology: The Cell Cycle-A Review: . Neurosurgery 1997;40:1000-15. [DOI: 10.1097/00006123-199705000-00025] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
246 Ramachandran S, Kwon KY, Shin SJ, Kwon SH, Cha SD, Bae I, Cho CH. Cyclin-dependent kinase inhibitor p27Kip1 controls growth and cell cycle progression in human uterine leiomyoma. J Korean Med Sci 2008;23:667-73. [PMID: 18756055 DOI: 10.3346/jkms.2008.23.4.667] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
247 Dowell SP, Hall PA. The clinical relevance of the p53 tumour suppressor gene. Cytopathology 1994;5:133-45. [PMID: 7919056 DOI: 10.1111/j.1365-2303.1994.tb00409.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
248 White E, Rao L, Chiou S, Tseng C, Sabbatini P, Gonzalez M, Verwaerde P. Regulation of Apoptosis by the Transforming Gene Products of Adenovirus. In: Mihich E, Schimke RT, editors. Apoptosis. Boston: Springer US; 1994. pp. 47-62. [DOI: 10.1007/978-1-4757-9217-1_4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
249 Del Sal G, Collavin L, Ruaro ME, Edomi P, Saccone S, Valle GD, Schneider C. Structure, function, and chromosome mapping of the growth-suppressing human homologue of the murine gas1 gene. Proc Natl Acad Sci U S A 1994;91:1848-52. [PMID: 8127893 DOI: 10.1073/pnas.91.5.1848] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 2.0] [Reference Citation Analysis]
250 Batsché E, Muchardt C, Behrens J, Hurst HC, Crémisi C. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 1998;18:3647-58. [PMID: 9632747 DOI: 10.1128/MCB.18.7.3647] [Cited by in Crossref: 115] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
251 Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH. Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci USA. 1994;91:11045-11049. [PMID: 7972006 DOI: 10.1073/pnas.91.23.11045] [Cited by in Crossref: 346] [Cited by in F6Publishing: 332] [Article Influence: 12.8] [Reference Citation Analysis]
252 Selvakumar P, Owens TA, David JM, Petrelli NJ, Christensen BC, Lakshmikuttyamma A, Rajasekaran AK. Epigenetic silencing of Na,K-ATPase β 1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma. Epigenetics 2014;9:579-86. [PMID: 24452105 DOI: 10.4161/epi.27795] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
253 Chial HJ, Giddings TH Jr, Siewert EA, Hoyt MA, Winey M. Altered dosage of the Saccharomyces cerevisiae spindle pole body duplication gene, NDC1, leads to aneuploidy and polyploidy. Proc Natl Acad Sci U S A 1999;96:10200-5. [PMID: 10468586 DOI: 10.1073/pnas.96.18.10200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
254 Lloyd RV. Introduction to molecular endocrine pathology. Endocr Pathol 1993;4:64-72. [DOI: 10.1007/bf02914454] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
255 Sgambato A, Flamini G, Cittadini A, Weinstein IB. Abnormalities in Cell Cycle Control in Cancer and Their Clinical Implications. Tumori 1998;84:421-33. [DOI: 10.1177/030089169808400401] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
256 Nilson LA, DiMaio D. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol Cell Biol 1993;13:4137-45. [PMID: 8321218 DOI: 10.1128/mcb.13.7.4137-4145.1993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 0.1] [Reference Citation Analysis]
257 Saenz-santamaria M, Mcnutt N, Shea C. Immunohistochemical expression of retinoblastoma protein in cutaneous melanomas. Br J Dermatol 1995;133:890-5. [DOI: 10.1111/j.1365-2133.1995.tb06921.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
258 Glassman M, Hochberg A. Time reversal in biological systems. Medical Hypotheses 1997;49:505-8. [DOI: 10.1016/s0306-9877(97)90069-4] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
259 Lu AL, Hsu IC. Detection of single DNA base mutations with mismatch repair enzymes. Genomics 1992;14:249-55. [PMID: 1427840 DOI: 10.1016/s0888-7543(05)80213-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
260 Lau AF, Kanemitsu MY, Kurata WE, Danesh S, Boynton AL. Epidermal growth factor disrupts gap-junctional communication and induces phosphorylation of connexin43 on serine. Mol Biol Cell 1992;3:865-74. [PMID: 1327298 DOI: 10.1091/mbc.3.8.865] [Cited by in Crossref: 135] [Cited by in F6Publishing: 133] [Article Influence: 4.7] [Reference Citation Analysis]
261 Ambros RA, Vigna PA, Figge J, Kallakury BVS, Mastrangelo A, Eastman AY, Malfetano J, Figge HL, Ross JS. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Cancer 1994;73:1686-92. [DOI: 10.1002/1097-0142(19940315)73:6<1686::aid-cncr2820730622>3.0.co;2-w] [Cited by in Crossref: 38] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
262 Corney DC, Flesken-Nikitin A, Choi J, Nikitin AY. Role of p53 and Rb in ovarian cancer. Adv Exp Med Biol 2008;622:99-117. [PMID: 18546622 DOI: 10.1007/978-0-387-68969-2_9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
263 Tada M, Kobayashi H, Moriuchi T. Molecular basis of pituitary oncogenesis. J Neurooncol 1999;45:83-96. [PMID: 10728913 DOI: 10.1023/a:1006390306336] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
264 Aaronson SA, Miki T, Meyers K, Chan A. Growth Factors and Malignant Transformation. In: Zappia V, Salvatore M, Della Ragione F, editors. Advances in Nutrition and Cancer. Boston: Springer US; 1993. pp. 7-22. [DOI: 10.1007/978-1-4615-2942-2_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
265 Bolande RP. Prenatal Exposures and Childhood Cancer. Pediatr Dev Pathol 1999;2:208-14. [DOI: 10.1007/s100249900115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
266 Boyle JO, Mao L, Brennan JA, Koch WM, Eisele DW, Saunders JR, Sidransky D. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. The American Journal of Surgery 1994;168:429-32. [DOI: 10.1016/s0002-9610(05)80092-3] [Cited by in Crossref: 84] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
267 Ohashi M, Kanai F, Ueno H, Tanaka T, Tateishi K, Kawakami T, Koike Y, Ikenoue T, Shiratori Y, Hamada H. Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo. Gut. 1999;44:366-371. [PMID: 10026322 DOI: 10.1136/gut.44.3.366] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
268 Toniolo P, Zhitkovich A, Costa M. Development and utilization of a new simple assay for DNA-protein crosslinks as a biomarker of exposure to welding fumes. Int Arch Occup Environ Heath 1993;65:S87-9. [DOI: 10.1007/bf00381313] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
269 Weinberg R, Lundberg A. Control of the cell cycle and apoptosis. European Journal of Cancer 1999;35:531-9. [DOI: 10.1016/s0959-8049(99)00046-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Harris CC. 1995 Deichmann Lecture—p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Toxicology Letters 1995;82-83:1-7. [DOI: 10.1016/0378-4274(95)03643-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
271 Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R, Weinstein IB. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A. 1993;90:9026-9030. [PMID: 8415648 DOI: 10.1073/pnas.90.19.9026] [Cited by in Crossref: 212] [Cited by in F6Publishing: 206] [Article Influence: 7.6] [Reference Citation Analysis]
272 Dahiya R, Lee C, McCarville J, Hu W, Kaur G, Deng G. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Int J Cancer 1997;72:762-7. [PMID: 9311591 DOI: 10.1002/(sici)1097-0215(19970904)72:5<762::aid-ijc10>3.0.co;2-b] [Cited by in Crossref: 58] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
273 Lara P. Molecular biology of prostate carcinogenesis. Critical Reviews in Oncology/Hematology;32:197-208. [DOI: 10.1016/s1040-8428(99)00041-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
274 Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993;13:320-30. [PMID: 8417334 DOI: 10.1128/mcb.13.1.320-330.1993] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
275 Wang LY, Li LS, Yang Z. Correlation of FOXC1 protein with clinicopathological features in serous ovarian tumors. Oncol Lett. 2016;11:933-938. [PMID: 26893671 DOI: 10.3892/ol.2015.3996] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
276 Zhao ZM, Zhao B, Bai Y, Iamarino A, Gaffney SG, Schlessinger J, Lifton RP, Rimm DL, Townsend JP. Early and multiple origins of metastatic lineages within primary tumors. Proc Natl Acad Sci U S A 2016;113:2140-5. [PMID: 26858460 DOI: 10.1073/pnas.1525677113] [Cited by in Crossref: 95] [Cited by in F6Publishing: 67] [Article Influence: 19.0] [Reference Citation Analysis]
277 Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 1995;267:381-3. [PMID: 7824936 DOI: 10.1126/science.7824936] [Cited by in Crossref: 569] [Cited by in F6Publishing: 470] [Article Influence: 21.9] [Reference Citation Analysis]
278 Singh BB, Chandler FW, Whitaker S, Forbes-nelson AE. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 1998;85:692-8. [DOI: 10.1016/s1079-2104(98)90037-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
279 Grafström RC, Norén UG, Zheng X, Elfwing Å, Sundqvist K. Growth and Transformation of Human Oral Epithelium In Vitro. In: Müller-hermelink HK, Neumann H, Dekant W, editors. Risk and Progression Factors in Carcinogenesis. Berlin: Springer Berlin Heidelberg; 1997. pp. 275-306. [DOI: 10.1007/978-3-642-60393-8_20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
280 Lgnotz RA. Transforming growth factor-beta1 induces expression of statin during differentiation of human promonocytic leukemia cells. J Cell Biochem 1992;50:285-92. [DOI: 10.1002/jcb.240500309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
281 Johnson MR, DeClue JE, Felzmann S, Vass WC, Xu G, White R, Lowy DR. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 1994;14:641-5. [PMID: 8264632 DOI: 10.1128/mcb.14.1.641-645.1994] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
282 Huang L, Garrett AP, Schorge JO, Muto MG, Bell DA, Welch WR, Berkowitz RS, Mok SC. Distinct Allelic Loss Patterns in Papillary Serous Carcinoma of the Peritoneum. American Journal of Clinical Pathology 2000;114:93-9. [DOI: 10.1309/p51m-b66m-jfkw-er5a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
283 Goldblum JR, Frank TS, Poy EL, Weiss SW. p53 Mutations and Tumor Progression in Well-differentiated Liposarcoma and Dermatofibrosarcoma Protuberans. Int J Surg Pathol 1995;3:35-41. [DOI: 10.1177/106689699500300106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
284 Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schäfer R. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol. 2001;159:1635-1643. [PMID: 11696424 DOI: 10.1016/S0002-9440(10)63010-6] [Cited by in Crossref: 185] [Cited by in F6Publishing: 81] [Article Influence: 9.3] [Reference Citation Analysis]
285 Niederacher D, Picard F, van Roeyen C, An H, Bender HG, Beckmann MW. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosom Cancer 1997;18:181-92. [DOI: 10.1002/(sici)1098-2264(199703)18:3<181::aid-gcc5>3.0.co;2-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
286 Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B, Simantov R, Kelley S. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov. 2006;5:835-844. [PMID: 17016424 DOI: 10.1038/nrd2130] [Cited by in Crossref: 1126] [Cited by in F6Publishing: 926] [Article Influence: 75.1] [Reference Citation Analysis]
287 Vermylen P, Roufosse C, Ninane V, Sculier JP. Biology of pulmonary preneoplastic lesions. Cancer Treat Rev 1997;23:241-62. [PMID: 9377595 DOI: 10.1016/s0305-7372(97)90013-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
288 Slack RS, Skerjanc IS, Lach B, Craig J, Jardine K, McBurney MW. Cells differentiating into neuroectoderm undergo apoptosis in the absence of functional retinoblastoma family proteins. J Cell Biol 1995;129:779-88. [PMID: 7730411 DOI: 10.1083/jcb.129.3.779] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 2.2] [Reference Citation Analysis]
289 Low KG, Chu HM, Schwartz PM, Daniels GM, Melner MH, Comb MJ. Novel interactions between human T-cell leukemia virus type I Tax and activating transcription factor 3 at a cyclic AMP-responsive element. Mol Cell Biol 1994;14:4958-74. [PMID: 8007991 DOI: 10.1128/mcb.14.7.4958-4974.1994] [Cited by in Crossref: 19] [Article Influence: 0.7] [Reference Citation Analysis]
290 Hacker SM, Mortensen F, Scheffner M, Marx A. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit. Angew Chem Int Ed Engl 2014;53:10247-50. [PMID: 25098403 DOI: 10.1002/anie.201405259] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
291 Morrissette JJ, Celle L, Owens NL, Shields CL, Zackai EH, Spinner NB. Boy with bilateral retinoblastoma due to an unusual ring chromosome 13 with activation of a latent centromere. Am J Med Genet 2001;99:21-8. [DOI: 10.1002/1096-8628(20010215)99:1<21::aid-ajmg1122>3.0.co;2-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
292 Yoshida K, Yasui W, Kagawa Y, Tahara E. Multiple Genetic Alterations and Abnormal Growth Factor Network in Human Esophageal Carcinomas. In: Tahara E, editor. Molecular Pathology of Gastroenterological Cancer. Tokyo: Springer Japan; 1997. pp. 31-41. [DOI: 10.1007/978-4-431-65915-0_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
293 Chang F, Syrjänen S, Tervahauta A, Syrjänen K. Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer 1993;68:653-61. [PMID: 8398688 DOI: 10.1038/bjc.1993.404] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 2.8] [Reference Citation Analysis]
294 Papageorgiou SG, Pappa V, Papageorgiou E, Tsirigotis P, Kontsioti F, Panani A, Dervenoulas J, Economopoulos T. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes. Eur J Haematol 2005;75:193-8. [PMID: 16104874 DOI: 10.1111/j.1600-0609.2005.00475.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
295 Fan Y, Sanyal S, Bruzzone R. Breaking Bad: How Viruses Subvert the Cell Cycle. Front Cell Infect Microbiol 2018;8:396. [PMID: 30510918 DOI: 10.3389/fcimb.2018.00396] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 15.3] [Reference Citation Analysis]
296 Rice JD, Tsodikov A. Semiparametric profile likelihood estimation for continuous outcomes with excess zeros in a random-threshold damage-resistance model. Stat Med 2017;36:1924-35. [PMID: 28192863 DOI: 10.1002/sim.7237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
297 Cheng RZ, Shammas MA, Li J, Reis RJ. Expression of SV40 Large T Antigen Stimulates Reversion of a Chromosomal Gene Duplication in Human Cells. Experimental Cell Research 1997;234:300-12. [DOI: 10.1006/excr.1997.3649] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
298 Bignold LP. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis. Cancer Lett. 2004;216:127-146. [PMID: 15533589 DOI: 10.1016/j.canlet.2004.07.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
299 Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. Int J Immunogenet 2007;34:213-7. [PMID: 17504512 DOI: 10.1111/j.1744-313X.2007.00678.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
300 Johnson MR, DeClue JE, Felzmann S, Vass WC, Xu G, White R, Lowy DR. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 1994;14:641-5. [PMID: 8264632 DOI: 10.1128/mcb.14.1.641-645.1994] [Cited by in Crossref: 65] [Article Influence: 2.4] [Reference Citation Analysis]
301 Ahlquist DA, Thibodeau SN. Will molecular genetic markers help predict the clinical behavior of colorectal neoplasia? Gastroenterology 1992;102:1419-21. [PMID: 1551551 DOI: 10.1016/0016-5085(92)90788-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
302 Narayanan VS, Fitch CA, Levenson CW. Tumor Suppressor Protein p53 mRNA and Subcellular Localization Are Altered by Changes in Cellular Copper in Human Hep G2 Cells. The Journal of Nutrition 2001;131:1427-32. [DOI: 10.1093/jn/131.5.1427] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
303 Mujoo K, Watanabe M, Khokhar AR, Siddik ZH. Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog. Prostate 2005;62:91-100. [PMID: 15389812 DOI: 10.1002/pros.20114] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
304 Kok S, Lee J, Hsu H, Chiang C, Kuo Y, Kuo MY. Mutations of the adenomatous polyposis coli gene in areca quid and tobacco-associated oral squamous cell carcinomas in Taiwan: Mutations of the APC gene in oral SCC. Journal of Oral Pathology & Medicine 2002;31:395-401. [DOI: 10.1034/j.1600-0714.2002.00118.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
305 Ozisik YY, Meloni AM, Zalupski MM, Ryan JR, Qureshi F, Sandberg AA. Deletion of chromosome 13 in osteosarcoma secondary to irradiation. Cancer Genetics and Cytogenetics 1993;69:35-7. [DOI: 10.1016/0165-4608(93)90109-y] [Cited by in Crossref: 17] [Article Influence: 0.6] [Reference Citation Analysis]
306 Müller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci U S A 1994;91:2945-9. [PMID: 8159685 DOI: 10.1073/pnas.91.8.2945] [Cited by in Crossref: 168] [Cited by in F6Publishing: 164] [Article Influence: 6.2] [Reference Citation Analysis]
307 Lin CW, Zhang DS, Kwiatkowski DJ, Shipley WU, Scott McDougal W, Yandell DW. Potential location of a bladder tumor suppressor gene on chromosome 9q at 9q13 to 9q22.1. Urol Oncol 1995;1:88-92. [PMID: 21224098 DOI: 10.1016/1078-1439(95)00024-c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
308 Wiseman RW, Cochran C, Dietrich W, Lander ES, Söderkvist P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl Acad Sci U S A 1994;91:3759-63. [PMID: 8170984 DOI: 10.1073/pnas.91.9.3759] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
309 Matsumine A, Senda T, Baeg GH, Roy BC, Nakamura Y, Noda M, Toyoshima K, Akiyama T. MCC, a cytoplasmic protein that blocks cell cycle progression from the G0/G1 to S phase. J Biol Chem 1996;271:10341-6. [PMID: 8626604 DOI: 10.1074/jbc.271.17.10341] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
310 Kiyokawa H, Richon VM, Rifkind RA, Marks PA. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 1994;14:7195-203. [PMID: 7935434 DOI: 10.1128/mcb.14.11.7195-7203.1994] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
311 Dees C, Travis C. Hyperphosphorylation of p53 induced by benzene, toluene, and chloroform. Cancer Letters 1994;84:117-23. [DOI: 10.1016/0304-3835(94)90365-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
312 Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, Rajasekaran AK. Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit. Histol Histopathol 2008;23:459-67. [PMID: 18228203 DOI: 10.14670/HH-23.459] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
313 Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993;13:4976-85. [PMID: 8336730 DOI: 10.1128/mcb.13.8.4976-4985.1993] [Cited by in F6Publishing: 142] [Reference Citation Analysis]
314 Traish AM, Huang YH, Ashba J, Pronovost M, Pavao M, McAneny DB, Moreland RB. Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer. Diagn Mol Pathol. 1997;6:209-221. [PMID: 9360842 DOI: 10.1097/00019606-199708000-00005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
315 Vargas MP, Vargas HI, Kleiner DE, Merino MJ. Adrenocortical Neoplasms: Role of Prognostic Markers MIB-1, P53, and RB: . The American Journal of Surgical Pathology 1997;21:556-62. [DOI: 10.1097/00000478-199705000-00008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
316 Kurose K, Iida A, Araki T, Sakamoto G, Kasumi F, Nakamura Y, Emi M. Frequent allelic loss at 7p14-15 associated with aggressive histologic types of breast cancer. Jpn J Cancer Res 1998;89:533-8. [PMID: 9685857 DOI: 10.1111/j.1349-7006.1998.tb03294.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
317 Clark DJ, Meijne EM, Bouffler SD, Huiskamp R, Skidmore CJ, Cox R, Silver AJ. Microsatellite analysis of recurrent chromosome 2 deletions in acute myeloid leukaemia induced by radiation in FI hybrid mice. Genes Chromosom Cancer 1996;16:238-46. [DOI: 10.1002/(sici)1098-2264(199608)16:4<238::aid-gcc3>3.0.co;2-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
318 Takebe A, Era T, Okada M, Martin Jakt L, Kuroda Y, Nishikawa S. Microarray analysis of PDGFR alpha+ populations in ES cell differentiation culture identifies genes involved in differentiation of mesoderm and mesenchyme including ARID3b that is essential for development of embryonic mesenchymal cells. Dev Biol 2006;293:25-37. [PMID: 16530748 DOI: 10.1016/j.ydbio.2005.12.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
319 Grati FR, Sirchia SM, Garagiola I, Sironi E, Galioto S, Rossella F, Serafini P, Dulcetti F, Bozzetti A, Brusati R, Simoni G. Losses of Heterozygosity in Oral and Oropharyngeal Epithelial Carcinomas. Cancer Genetics and Cytogenetics 2000;118:57-61. [DOI: 10.1016/s0165-4608(99)00199-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
320 Chao R, Khan W, Hannun Y. Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. Journal of Biological Chemistry 1992;267:23459-62. [DOI: 10.1016/s0021-9258(18)35858-7] [Cited by in Crossref: 43] [Article Influence: 1.5] [Reference Citation Analysis]
321 Dees C, Godfrey V, Foster J, Schultz R, Travis C. Stabilization of the p53 gene product in two bovine leukemia virus infected cell lines. Cancer Letters 1994;86:33-40. [DOI: 10.1016/0304-3835(94)90177-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
322 Berry C. Can chemicals be loved?--A problem for 2000. Toxicol Lett 1995;82-83:725-9. [PMID: 8597133 DOI: 10.1016/0378-4274(95)03516-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
323 Perez CA. Quest for excellence: The ultimate goal of the radiation oncologist: ASTRO gold medal address, 1992. International Journal of Radiation Oncology*Biology*Physics 1993;26:567-80. [DOI: 10.1016/0360-3016(93)90272-w] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
324 Fey MF. Microsatellite Markers in Leukaemia and Lymphoma: Comments on a Timely Topic. Leukemia & Lymphoma 2009;28:11-22. [DOI: 10.3109/10428199709058326] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
325 Bukovsky A, Caudle MR, Keenan JA, Wimalasena J, Foster JS, Upadhyaya NB, van Meter SE. Expression of cell cycle regulatory proteins (p53, pRb) in the human female genital tract. J Assist Reprod Genet 1995;12:123-31. [PMID: 7670270 DOI: 10.1007/BF02211381] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
326 Karayi MK, Markham AF. Molecular biology of prostate cancer. Prostate Cancer Prostatic Dis. 2004;7:6-20. [PMID: 14999233 DOI: 10.1038/sj.pcan.4500697] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
327 Fong KM, Zimmerman PV, Smith PJ. Correlation of loss of heterozygosity at 11 p with tumour progression and survival in non-small cell lung cancer. Genes Chromosom Cancer 1994;10:183-9. [DOI: 10.1002/gcc.2870100306] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.4] [Reference Citation Analysis]
328 Liang SX, Chambers SK, Cheng L, Zhang S, Zhou Y, Zheng W. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Int J Surg Pathol 2004;12:319-31. [PMID: 15494858 DOI: 10.1177/106689690401200405] [Cited by in Crossref: 46] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
329 Mori N, Morosetti R, Spira S, Lee S, Ben-yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP. Chromosome Band 1p36 Contains a Putative Tumor Suppressor Gene Important in the Evolution of Chronic Myelocytic Leukemia. Blood 1998;92:3405-9. [DOI: 10.1182/blood.v92.9.3405] [Cited by in Crossref: 52] [Article Influence: 2.3] [Reference Citation Analysis]
330 Grewal R, Cucuianu A, Swanepoel C, Dima D, Petrushev B, Pop B, Berindan-Neagoe I, Abayomi EA, Tomuleasa C. The role of microRNAs in the pathogenesis of HIV-related lymphomas. Crit Rev Clin Lab Sci 2015;52:232-41. [PMID: 26218036 DOI: 10.3109/10408363.2015.1030063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
331 Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161:205-214. [PMID: 25860605 DOI: 10.1016/j.cell.2015.03.030] [Cited by in Crossref: 1194] [Cited by in F6Publishing: 997] [Article Influence: 199.0] [Reference Citation Analysis]
332 Chim C, Kwong Y. Adverse prognostic impact of CDKN2B hyper-methylationin acute promyelocytic leukemia. Leukemia & Lymphoma 2009;47:815-25. [DOI: 10.1080/10428190500513827] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
333 Ko J, Lee YH, Hwang SY, Lee YS, Shin SM, Hwang JH, Kim J, Kim YW, Jang SW, Ryoo ZY. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene. 2003;22:4679-4689. [PMID: 12879013 DOI: 10.1038/sj.onc.1206624] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
334 Lampl M. Evidence of saltatory growth in infancy. Am J Hum Biol 1993;5:641-52. [DOI: 10.1002/ajhb.1310050607] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
335 Endo A, Kano Y, Mihara K, Orita K, Namba M. Alteration in the retinoblastoma gene associated with immortalization of human fibroblasts treated with60Co gamma rays. J Cancer Res Clin Oncol 1993;119:522-6. [DOI: 10.1007/bf01686461] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
336 Hijiya N, Gewirtz AM. Oncogenes, Molecular Medicine, and Bone Marrow Transplantation. Journal of Hematotherapy 1992;1:369-78. [DOI: 10.1089/scd.1.1992.1.369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
337 Xie X, Shen J, Xu L, Li E, Shen Z. Bronchogenic and alveologenic tumors in mice induced by N -nitrosopiperidineThis paper is one of a selection of papers published in this special issue entitled “Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine” and has undergone the Journal's usual peer review process. Biochem Cell Biol 2010;88:775-82. [DOI: 10.1139/o10-019] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
338 Unek G, Ozmen A, Mendilcioglu I, Simsek M, Korgun ET. Immunohistochemical distribution of cell cycle proteins p27, p57, cyclin D3, PCNA and Ki67 in normal and diabetic human placentas. J Mol Hist 2014;45:21-34. [DOI: 10.1007/s10735-013-9534-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
339 Fang DC, Jass JR, Wang DX. Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol. 1998;51:593-596. [PMID: 9828817 DOI: 10.1136/jcp.51.8.593] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
340 Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 1993;122:685-701. [PMID: 8335693 DOI: 10.1083/jcb.122.3.685] [Cited by in Crossref: 245] [Cited by in F6Publishing: 211] [Article Influence: 8.8] [Reference Citation Analysis]
341 Brunton VG, Workman P. Cell-signaling targets for antitumour drug development. Cancer Chemother Pharmacol 1993;32:1-19. [DOI: 10.1007/bf00685870] [Cited by in Crossref: 38] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
342 Zhang S, Bauer B, Mitsunaga S, Goodrow TL, Klein-szanto AJP. Lack of concordantp53 mutations in some paired primary and metastatic mouse squamous cell carcinomas induced by chemical carcinogenesis. Mol Carcinog 1995;12:77-81. [DOI: 10.1002/mc.2940120204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
343 Kim JW, Kim TE, Kim YK, Kim YW, Kim SJ, Lee JM, Kim IK, Namkoong SE. Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines. Antisense Nucleic Acid Drug Dev 1999;9:507-13. [PMID: 10645776 DOI: 10.1089/oli.1.1999.9.507] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
344 Chim CS, Liang R, Kwong YL. Hypermethylation of gene promoters in hematological neoplasia. Hematol Oncol. 2002;20:167-176. [PMID: 12469326 DOI: 10.1002/hon.694] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 4.5] [Reference Citation Analysis]
345 Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med. 1995;18:775-794. [PMID: 7750801 DOI: 10.1016/0891-5849(94)00198-s] [Cited by in Crossref: 832] [Cited by in F6Publishing: 204] [Article Influence: 32.0] [Reference Citation Analysis]
346 Weinberg RA. The Molecular Basis of Oncogenes and Tumor Suppressor Genes. Ann NY Acad Sci 1995;758:331-8. [DOI: 10.1111/j.1749-6632.1995.tb24838.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 3.1] [Reference Citation Analysis]
347 Watling CJ, van Meyel DJ, Ramsay DA, Macdonald DR, Cairncross JG. Loss of Heterozygosity Analysis of Chromosomes 9, 10 and 17 in Gliomas in Families. Can j neurol sci 1995;22:17-21. [DOI: 10.1017/s0317167100040440] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
348 Hatakeyama M, Weinberg RA. The role of RB in cell cycle control. Prog Cell Cycle Res 1995;1:9-19. [PMID: 9552350 DOI: 10.1007/978-1-4615-1809-9_2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 3.7] [Reference Citation Analysis]
349 Irie A, Bouffard DY, Scanlon KJ. Ribozyme-Mediated Cancer Gene Therapy. Int J Urol 1997;4:329-37. [DOI: 10.1111/j.1442-2042.1997.tb00203.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
350 Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA. 1994;91:9700-9704. [PMID: 7937876 DOI: 10.1073/pnas.91.21.9700] [Cited by in Crossref: 987] [Cited by in F6Publishing: 885] [Article Influence: 36.6] [Reference Citation Analysis]
351 Dohadwala M, da Cruz e Silva EF, Hall FL, Williams RT, Carbonaro-Hall DA, Nairn AC, Greengard P, Berndt N. Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc Natl Acad Sci U S A 1994;91:6408-12. [PMID: 8022797 DOI: 10.1073/pnas.91.14.6408] [Cited by in Crossref: 182] [Cited by in F6Publishing: 174] [Article Influence: 6.7] [Reference Citation Analysis]
352 de Leon MP. Oncogenes and Tumor Suppressor Genes. Familial and Hereditary Tumors. Berlin: Springer Berlin Heidelberg; 1994. pp. 35-47. [DOI: 10.1007/978-3-642-85076-9_4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
353 Beijersbergen RL, Bernards R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1996;1287:103-20. [PMID: 8672526 DOI: 10.1016/0304-419x(96)00002-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 42] [Article Influence: 0.8] [Reference Citation Analysis]
354 Mullen CA. Review: Analogies Between Trophoblastic and Malignant Cells. American Journal of Reproductive Immunology 1998;39:41-9. [DOI: 10.1111/j.1600-0897.1998.tb00332.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
355 Lampl M, Johnson M. A case study of daily growth during adolescence: a single spurt or changes in the dynamics of saltatory growth? Annals of Human Biology 2009;20:595-603. [DOI: 10.1080/03014469300003002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
356 Angel JM, Morizot DC, Richie ER. Localization of a novel chromosome 7 locus that suppresses development ofN-methyl-N-nitrosourea—induced murine thymic lymphomas. Mol Carcinog 1993;7:151-6. [DOI: 10.1002/mc.2940070305] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
357 Kurzik-dumke U, Gundacker D, Rentrop M, Gateff E. Tumor suppression inDrosophila is causally related to the function of thelethal(2)tumorous imaginal discs gene, adnaJ homolog. Dev Genet 1995;16:64-76. [DOI: 10.1002/dvg.1020160110] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]
358 Wang XL, Uzawa K, Miyakawa A, Shiiba M, Watanabe T, Sato T, Miya T, Yokoe H, Tanzawa H. Localization of a tumour-suppressor gene associated with human oral cancer on 7q31.1. Int J Cancer 1998;75:671-4. [PMID: 9495232 DOI: 10.1002/(sici)1097-0215(19980302)75:5<671::aid-ijc2>3.0.co;2-w] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
359 Johnson MR, Look AT, DeClue JE, Valentine MB, Lowy DR. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. Proc Natl Acad Sci U S A 1993;90:5539-43. [PMID: 8516298 DOI: 10.1073/pnas.90.12.5539] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 3.5] [Reference Citation Analysis]
360 Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. J Neuropathol Exp Neurol 2005;64:398-403. [PMID: 15892297 DOI: 10.1093/jnen/64.5.398] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
361 Rao SS, Kohtz DS. Positive and Negative Regulation of D-type Cyclin Expression in Skeletal Myoblasts by Basic Fibroblast Growth Factor and Transforming Growth Factor β. Journal of Biological Chemistry 1995;270:4093-100. [DOI: 10.1074/jbc.270.8.4093] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 4.0] [Reference Citation Analysis]
362 Granados López AJ, López JA. Multistep model of cervical cancer: participation of miRNAs and coding genes. Int J Mol Sci 2014;15:15700-33. [PMID: 25192291 DOI: 10.3390/ijms150915700] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
363 Cui C, Kakeya H, Osada H. Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase. Tetrahedron 1996;52:12651-66. [DOI: 10.1016/0040-4020(96)00737-5] [Cited by in Crossref: 382] [Cited by in F6Publishing: 166] [Article Influence: 15.3] [Reference Citation Analysis]
364 Sánchez-Fayos Calabuig P, Martín Relloso MJ, Porres Cubero JC. [Genetic profile and molecular bases of pancreatic carcinogenesis]. Gastroenterol Hepatol 2007;30:592-6. [PMID: 18028855 DOI: 10.1157/13112587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
365 Chan AM, Miki T, Meyers KA, Aaronson SA. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. Proc Natl Acad Sci U S A 1994;91:7558-62. [PMID: 8052619 DOI: 10.1073/pnas.91.16.7558] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 2.3] [Reference Citation Analysis]
366 Oliner JD. Discerning the function of p53 by examining its molecular interactions. Bioessays 1993;15:703-7. [DOI: 10.1002/bies.950151102] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
367 Tam SK, Gu W, Mahdavi V, Nadal-Ginard B. Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann N Y Acad Sci 1995;752:72-9. [PMID: 7755297 DOI: 10.1111/j.1749-6632.1995.tb17407.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
368 Mayer NJ, Rubin SA. Molecular and cellular prospects for repair, augmentation, and replacement of the failing heart. American Heart Journal 1997;134:577-86. [DOI: 10.1016/s0002-8703(97)70098-x] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
369 DePriest PD, Banks ER, Powell DE, van Nagell JR Jr, Gallion HH, Puls LE, Hunter JE, Kryscio RJ, Royalty MB. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women. Gynecol Oncol 1992;47:71-5. [PMID: 1427405 DOI: 10.1016/0090-8258(92)90079-x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
370 Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-miñaur S, Bohring A, Lacombe D, Stewart F, Fiskerstrand T, Bindoff L, Berland S, Adès LC, Tchan M, David A, Wilson LC, Hennekam RCM, Donnai D, Mansour S, Cormier-daire V, Robertson SP. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet 2009;41:95-100. [DOI: 10.1038/ng.270] [Cited by in Crossref: 142] [Cited by in F6Publishing: 90] [Article Influence: 10.9] [Reference Citation Analysis]
371 Zhu X, Mancini MA, Chang KH, Liu CY, Chen CF, Shan B, Jones D, Yang-Feng TL, Lee WH. Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression. Mol Cell Biol 1995;15:5017-29. [PMID: 7651420 DOI: 10.1128/MCB.15.9.5017] [Cited by in Crossref: 104] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
372 Mamede AC, Carvalho MJ, Abrantes AM, Laranjo M, Maia CJ, Botelho MF. Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res 2012;349:447-58. [PMID: 22592624 DOI: 10.1007/s00441-012-1424-6] [Cited by in Crossref: 172] [Cited by in F6Publishing: 138] [Article Influence: 19.1] [Reference Citation Analysis]
373 Mitry RR, Mansour MR, Havlík R, Habib NA. Gene therapy for liver tumours. Adv Exp Med Biol. 2000;465:193-205. [PMID: 10810627 DOI: 10.1007/0-306-46817-4_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
374 Tennant RW, Zeiger E. Genetic toxicology: current status of methods of carcinogen identification. Environ Health Perspect 1993;100:307-15. [PMID: 8354178 DOI: 10.1289/ehp.93100307] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
375 Calin GA, Vasilescu C, Negrini M, Barbanti-Brodano G. Genetic chaos and antichaos in human cancers. Med Hypotheses 2003;60:258-62. [PMID: 12606244 DOI: 10.1016/s0306-9877(02)00383-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
376 Brasier JL, Henske EP. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest 1997;99:194-9. [PMID: 9005987 DOI: 10.1172/JCI119147] [Cited by in Crossref: 178] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
377 Sáenz Robles MT, Symonds H, Chen J, Van Dyke T. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen. Mol Cell Biol 1994;14:2686-98. [PMID: 8139568 DOI: 10.1128/mcb.14.4.2686-2698.1994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 26] [Article Influence: 0.1] [Reference Citation Analysis]
378 Saijo M, Kato MV, Sasaki MS, Ishizaki K, Taya Y. Inactivation of oncoprotein binding by a single Cys 706 -to-Tyr substitution in the retinoblastoma protein. FEBS Letters 1994;340:181-4. [DOI: 10.1016/0014-5793(94)80133-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
379 Huang HY, Li J, Tang Y, Huang YX, Chen YG, Xie YY, Zhou ZY, Chen XY, Ding SY, Luo MF, Jin CN, Zhao LS, Xu JT, Zhou Y, Lin YC, Hong HC, Zuo HL, Hu SY, Xu PY, Li X, Huang HD. MethHC 2.0: information repository of DNA methylation and gene expression in human cancer. Nucleic Acids Res 2021;49:D1268-75. [PMID: 33270889 DOI: 10.1093/nar/gkaa1104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
380 Foulkes WD, Ragoussis J, Stamp GW, Allan GJ, Trowsdale J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 1993;67:551-9. [PMID: 8094976 DOI: 10.1038/bjc.1993.101] [Cited by in Crossref: 62] [Cited by in F6Publishing: 80] [Article Influence: 2.2] [Reference Citation Analysis]
381 Ullrich S, Anderson C, Mercer W, Appella E. The p53 tumor suppressor protein, a modulator of cell proliferation. Journal of Biological Chemistry 1992;267:15259-62. [DOI: 10.1016/s0021-9258(19)49524-0] [Cited by in Crossref: 91] [Article Influence: 3.1] [Reference Citation Analysis]
382 Dairkee SH, Smith HS. Genetic analysis of breast cancer progression. J Mammary Gland Biol Neoplasia 1996;1:139-51. [DOI: 10.1007/bf02013638] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
383 Schneider A, Rohr S, Kelly MD, Mitry R, Pignatelli M, Doré CJ, Gaub M, Jaeck D, Meyer C, Oudet P, Habib NA. Microsatellite Instability And Allelic Imbalance In Primary And Secondary Colorectal Cancer: MICROSATELLITE ALTERATIONS IN CRC. Aust N Z J Surg 2000;70:587-92. [DOI: 10.1046/j.1440-1622.2000.01904.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
384 Scholes AGM, Field JK. Genomic Instability in Head and Neck Cancer. In: Seifert G, editor. Oral Pathology. Berlin: Springer Berlin Heidelberg; 1996. pp. 201-22. [DOI: 10.1007/978-3-642-80169-3_7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
385 Irie A, Kijima H, Ohkawa T, Bouffard DY, Suzuki T, Curcio LD, Holm PS, Sassani A, Scanlon KJ. Anti-oncogene ribozymes for cancer gene therapy. Adv Pharmacol 1997;40:207-57. [PMID: 9217927 DOI: 10.1016/s1054-3589(08)60141-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
386 Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA, Marks PA. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Proc Natl Acad Sci U S A 1993;90:6746-50. [PMID: 8341693 DOI: 10.1073/pnas.90.14.6746] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
387 Kipps TJ. Gene Therapy for Cancer. Journal of Hematotherapy 1993;2:367-72. [DOI: 10.1089/scd.1.1993.2.367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
388 Connor CE, Burrows J, Hearps AC, Woods GM, Lowenthal RM, Ragg SJ. Cell cycle arrest of hematopoietic cell lines after treatment with ceramide is commonly associated with retinoblastoma activation. Cytometry 2001;43:164-9. [DOI: 10.1002/1097-0320(20010301)43:3<164::aid-cyto1044>3.0.co;2-o] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
389 Michor F, Iwasa Y, Nowak MA. Dynamics of cancer progression. Nat Rev Cancer 2004;4:197-205. [PMID: 14993901 DOI: 10.1038/nrc1295] [Cited by in Crossref: 268] [Cited by in F6Publishing: 188] [Article Influence: 15.8] [Reference Citation Analysis]
390 Adolph S, Brusselbach S, Muller R. Inhibition of transcription blocks cell cycle progression of NIH3T3 fibroblasts specifically in G1. Journal of Cell Science 1993;105:113-22. [DOI: 10.1242/jcs.105.1.113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
391 Declue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowy DR. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 1992;69:265-73. [DOI: 10.1016/0092-8674(92)90407-4] [Cited by in Crossref: 404] [Cited by in F6Publishing: 369] [Article Influence: 13.9] [Reference Citation Analysis]
392 Loeb LA. Cancer Cells Exhibit a Mutator Phenotype. Elsevier; 1997. pp. 25-56. [DOI: 10.1016/s0065-230x(08)60699-5] [Cited by in Crossref: 133] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
393 Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 1995;81:197-205. [PMID: 7537636 DOI: 10.1016/0092-8674(95)90329-1] [Cited by in Crossref: 511] [Cited by in F6Publishing: 426] [Article Influence: 19.7] [Reference Citation Analysis]
394 Kim YW, Otterson GA, Kratzke RA, Coxon AB, Kaye FJ. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein. Mol Cell Biol 1994;14:7256-64. [PMID: 7935440 DOI: 10.1128/mcb.14.11.7256-7264.1994] [Cited by in Crossref: 33] [Article Influence: 1.2] [Reference Citation Analysis]
395 Ayer DE, Lawrence QA, Eisenman RN. Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 1995;80:767-76. [DOI: 10.1016/0092-8674(95)90355-0] [Cited by in Crossref: 418] [Cited by in F6Publishing: 427] [Article Influence: 16.1] [Reference Citation Analysis]
396 Landegren U. Detection of mutations in human DNA. Genetic Analysis: Biomolecular Engineering 1992;9:3-8. [DOI: 10.1016/1050-3862(92)90023-x] [Cited by in Crossref: 10] [Article Influence: 0.3] [Reference Citation Analysis]
397 Steiner MS, Satterwhite DJ, Moses HL. Molecular insights into altered cell cycle regulation and genitourinary malignancy. Urologic Oncology: Seminars and Original Investigations 1995;1:3-17. [DOI: 10.1016/1078-1439(95)00005-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
398 Weber KL, Bolander ME, Rock MG, Pritchard D, Sarkar G. Evidence for the upregulation of osteogenic protein-1 mRNA expression in musculoskeletal neoplasms. J Orthop Res 1998;16:8-14. [DOI: 10.1002/jor.1100160103] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
399 Mukhopadhyay D, Datta K. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors. Seminars in Cancer Biology 2004;14:123-30. [DOI: 10.1016/j.semcancer.2003.09.019] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 3.9] [Reference Citation Analysis]
400 Shiio Y, Yamamoto T, Yamaguchi N. Negative regulation of Rb expression by the p53 gene product. Proc Natl Acad Sci U S A 1992;89:5206-10. [PMID: 1608930 DOI: 10.1073/pnas.89.12.5206] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 3.1] [Reference Citation Analysis]
401 Nakanishi M, Kaneko Y, Matsushime H, Ikeda K. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein. Biochem Biophys Res Commun 1999;263:35-40. [PMID: 10486249 DOI: 10.1006/bbrc.1999.1296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
402 de Nooij-van Dalen AG, van Buuren-van Seggelen VHA, Lohman PHM, Giphart-gassler M. Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro. Genes Chromosom Cancer 1998;21:30-8. [DOI: 10.1002/(sici)1098-2264(199801)21:1<30::aid-gcc5>3.0.co;2-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
403 Nishikawa T, Salim EI, Morimura K, Kaneko M, Ogawa M, Kinoshita A, Osugi H, Kinoshita H, Fukushima S. High susceptibility of p53 knockout mice to esophageal and urinary bladder carcinogenesis induced by N, N-dibutylnitrosamine. Cancer Letters 2003;194:45-54. [DOI: 10.1016/s0304-3835(03)00057-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
404 Lander JK, Fan H. Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice. J Virol 1997;71:3940-52. [DOI: 10.1128/jvi.71.5.3940-3952.1997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
405 Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, Lee DC. Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol Cell Biol 1993;13:320-30. [PMID: 8417334 DOI: 10.1128/mcb.13.1.320-330.1993] [Cited by in Crossref: 82] [Article Influence: 2.9] [Reference Citation Analysis]
406 Bouffler S, Silver A, Cox R. The role of DNA repeats and associated secondary structures in genomic instability and neoplasia. Bioessays 1993;15:409-12. [DOI: 10.1002/bies.950150607] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
407 Hiebert SW. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 1993;13:3384-91. [PMID: 8497257 DOI: 10.1128/mcb.13.6.3384-3391.1993] [Cited by in Crossref: 93] [Article Influence: 3.3] [Reference Citation Analysis]
408 Kotani A, Witek MA, Osiri JK, Wang H, Sinville R, Pincas H, Barany F, Soper SA. EndoV/DNA ligase mutation scanning assay using microchip capillary electrophoresis and dual-color laser-induced fluorescence detection. Anal Methods 2012;4:58-64. [DOI: 10.1039/c1ay05366c] [Cited by in Crossref: 28] [Cited by in F6Publishing: 1] [Article Influence: 3.1] [Reference Citation Analysis]
409 Rao SS, Chu C, Kohtz DS. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol 1994;14:5259-67. [PMID: 8035804 DOI: 10.1128/mcb.14.8.5259-5267.1994] [Cited by in Crossref: 119] [Article Influence: 4.4] [Reference Citation Analysis]
410 Baier LJ, Shors T, Shors ST, Jacobs BL. The mouse antiphosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase, PKR. Nucleic Acids Res 1993;21:4830-5. [PMID: 7694235 DOI: 10.1093/nar/21.20.4830] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
411 Amin MA, Awadein MR, Gabr H. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro. Chin J Dig Dis 2005;6:142-8. [PMID: 16045605 DOI: 10.1111/j.1443-9573.2005.00207.x] [Reference Citation Analysis]
412 Ndiaye R, Dem A, Mbaye PM, Guèye PM, Diop G, Diop PA, Faye O. [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal]. Bull Cancer 2014;101:789-94. [PMID: 25025520 DOI: 10.1684/bdc.2014.1911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
413 Rezende TMB, Freire MDS, Franco OL. Head and neck cancer: Proteomic advances and biomarker achievements. Cancer 2010;116:4914-25. [DOI: 10.1002/cncr.25245] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
414 Wendtner CM, Radulescu RT. Prediction of homologous binding sites on RB and p107 common for viral oncoproteins and cellular ligands. J Mol Recognit 1992;5:125-32. [DOI: 10.1002/jmr.300050402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
415 Liao C, Zhao MJ, Zhao J, Song H, Pineau P, Marchio A, Dejean A, Tiollais P, Wang HY, Li TP. Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma. World J Gastroenterol. 2003;9:89-93. [DOI: 10.3748/wjg.v9.i1.89] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
416 Demetrick DJ. Molecular Biology Primer for the Pediatric Pathologist. Pediatric Pathology 2009;14:339-67. [DOI: 10.3109/15513819409024264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
417 Yang G, Gong Y, Wang Q, Wang Y, Zhang X. The role of miR-100-mediated Notch pathway in apoptosis of gastric tumor cells. Cell Signal. 2015;27:1087-1101. [PMID: 25703026 DOI: 10.1016/j.cellsig.2015.02.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
418 Gu X, Shin B, Akbarali Y, Weiss A, Boltax J, Oettgen P, Libermann TA. Tel-2 Is a Novel Transcriptional Repressor Related to the Ets Factor Tel/ETV-6. Journal of Biological Chemistry 2001;276:9421-36. [DOI: 10.1074/jbc.m010070200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
419 Brennan JA, Sidransky D. Molecular staging of head and neck squamous carcinoma. Cancer Metast Rev 1996;15:3-10. [DOI: 10.1007/bf00049484] [Cited by in Crossref: 33] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
420 Wu WJ, Kakehi Y, Habuchi T, Kinoshita H, Ogawa O, Terachi T, Huang CH, Chiang CP, Yoshida O. Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers. Jpn J Cancer Res 1995;86:730-6. [PMID: 7559095 DOI: 10.1111/j.1349-7006.1995.tb02461.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.4] [Reference Citation Analysis]
421 Sant'anna JRD, Franco CCDS, Miyamoto CT, Cunico MM, Miguel OG, Côcco LC, Yamamoto CI, Junior CC, Castro-prado MAAD. Genotoxicity of Achillea millefolium essential oil in diploid cells of Aspergillus nidulans: GENOTOXIC ACTIVITY OF A. MILLEFOLIUM OIL. Phytother Res 2009;23:231-5. [DOI: 10.1002/ptr.2596] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
422 Seth A, Gupta S, Davis RJ. Cell cycle regulation of the c-Myc transcriptional activation domain. Mol Cell Biol 1993;13:4125-36. [PMID: 8321217 DOI: 10.1128/mcb.13.7.4125-4136.1993] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
423 Drexler HG, Borkhardt A, Janssen JWG. Detection of Chromosomal Translocations :in Leukemia-Lymphoma Cells by Polymerase Chain Reaction. Leukemia & Lymphoma 2009;19:359-80. [DOI: 10.3109/10428199509112194] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
424 Kalman D, Whittaker K, Bishop JM, O'Lague PH. Domains of E1A that bind p105Rb, p130, and p300 are required to block nerve growth factor-induced neurite growth in PC12 cells. Mol Biol Cell 1993;4:353-61. [PMID: 8507895 DOI: 10.1091/mbc.4.4.353] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
425 Berger AH, Pandolfi PP. Haplo-insufficiency: a driving force in cancer. J Pathol. 2011;223:137-146. [PMID: 21125671 DOI: 10.1002/path.2800] [Cited by in Crossref: 89] [Cited by in F6Publishing: 76] [Article Influence: 8.1] [Reference Citation Analysis]
426 Szarka CE, Grana G, Engstrom PF. Chemoprevention of cancer. Current Problems in Cancer 1994;18:6-79. [DOI: 10.1016/0147-0272(94)90003-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
427 Roth JA. Modulation of oncogene and tumor-suppressor gene expression: A novel strategy for cancer prevention and treatment. Annals of Surgical Oncology 1994;1:79-86. [DOI: 10.1007/bf02303545] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
428 Hong D, Mori N, Umesako S, Song C, Park Y, Aizawa S, Okumoto M. Putative Tumor-suppressor Gene Regions Responsible for Radiation Lymphomagenesis in F1 Mice with Different p53 Status. JRR;43:175-175. [DOI: 10.1269/jrr.43.175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
429 Hatta Y, Hirama T, Takeuchi S, Lee E, Pham E, Miller CW, Strohmeyer T, Wilczynski SP, Melmed S, Koeffler HP. Alterations of the p16 (MTS1) Gene in Testicular, Ovarian, and Endometrial Malignancies. Journal of Urology 1995;154:1954-7. [DOI: 10.1016/s0022-5347(01)66833-2] [Cited by in Crossref: 28] [Article Influence: 1.1] [Reference Citation Analysis]
430 Inomata M, Kaneko A, Saijo N, Tokura S. Culture of retinoblastoma cells from clinical specimens: growth-promoting effect of 2-Mercaptoethanol. J Cancer Res Clin Oncol 1994;120:149-55. [DOI: 10.1007/bf01202193] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
431 Wilding J, Meijne E, Haines J, Moody J, Edwards A, Newbold RF, Parris C, Cox R, Silver A. Functional evidence from microcell-mediated chromosome transfer of myeloid leukemia suppressor genes on human chromosomes 7 and 11. Genes Chromosomes Cancer 2002;34:390-7. [PMID: 12112528 DOI: 10.1002/gcc.10086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
432 Waldman SA, Terzic A. A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer. FEBS J 2009;276:2157-64. [PMID: 19250312 DOI: 10.1111/j.1742-4658.2009.06934.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
433 Watkins D, Dion F, Poisson M, Delattre JY, Rouleau GA. Analysis of oncogene expression in primary human gliomas: evidence for increased expression of the ros oncogene. Cancer Genet Cytogenet 1994;72:130-6. [PMID: 8143271 DOI: 10.1016/0165-4608(94)90128-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
434 Nakagawa T, Matozaki S. The SKM-1 leukemic cell line established from a patient with progression to myelomonocytic leukemia in myelodysplastic syndrome (MDS)-contribution to better understanding of MDS. Leuk Lymphoma 1995;17:335-9. [PMID: 8580805 DOI: 10.3109/10428199509056841] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
435 Sharma A, Rani R. An integrated framework for identification of effective and synergistic anti-cancer drug combinations. J Bioinform Comput Biol 2018;16:1850017. [PMID: 30304987 DOI: 10.1142/S0219720018500178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
436 Zenklusen JC, Conti CJ. Cytogenetic, molecular, and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7. Mol Carcinog 1996;15:167-75. [DOI: 10.1002/(sici)1098-2744(199603)15:3<167::aid-mc2>3.0.co;2-f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
437 Meijne E, Huiskamp R, Haines J, Moody J, Finnon R, Wilding J, Spanjer S, Bouffler S, Edwards A, Cox R, Silver A. Analysis of loss of heterozygosity in lymphoma and leukaemia arising in F1 hybrid mice locates a common region of chromosome 4 loss. Genes Chromosom Cancer 2001;31:373-81. [DOI: 10.1002/gcc.1156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
438 Iuliano R, Trapasso F, Stella A, Le Pera I, Melillo RM, Bruni P, Baldassarre G, Chiariotti L, Santoro M, Viglietto G, Fusco A. Pivotal Role of the RB Family Proteins in in Vitro Thyroid Cell Transformation. Experimental Cell Research 2000;260:257-67. [DOI: 10.1006/excr.2000.5023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
439 Leon SP, Zhu J, Black PM. Genetic Aberrations in Human Brain Tumors: . Neurosurgery 1994;34:708-22. [DOI: 10.1227/00006123-199404000-00021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.2] [Reference Citation Analysis]
440 Kaneshima EN, Castro-prado MAAD. Benznidazole-induced genotoxicity in diploid cells of Aspergillus nidulans. Mem Inst Oswaldo Cruz 2005;100:325-30. [DOI: 10.1590/s0074-02762005000300020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
441 Sherratt JA. Cellular Growth Control and Travelling Waves of Cancer. SIAM J Appl Math 1993;53:1713-30. [DOI: 10.1137/0153079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
442 Brookman-Amissah N, Nariculam J, Freeman A, Willamson M, Kirby RS, Masters JR, Feneley MR. Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse. Cancer Genet Cytogenet 2007;179:118-26. [PMID: 18036398 DOI: 10.1016/j.cancergencyto.2007.08.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
443 Moradpour D, Wands JR. The molecular pathogenesis of hepatocellular carcinoma. Journal of Viral Hepatitis 1994;1:17-31. [DOI: 10.1111/j.1365-2893.1994.tb00058.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
444 Prechtel D, Werenskiold AK, Prechtel K, Keller G, Höfler H. Frequent Loss of Heterozygosity at Chromosome 13q12–13 with BRCA2 Markers in Sporadic Male Breast Cancer: . Diagnostic Molecular Pathology 1998;7:57-62. [DOI: 10.1097/00019606-199802000-00010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
445 Monnat RJ Jr, Hackmann AF, Chiaverotti TA. Nucleotide sequence analysis of human hypoxanthine phosphoribosyltransferase (HPRT) gene deletions. Genomics 1992;13:777-87. [PMID: 1639404 DOI: 10.1016/0888-7543(92)90153-j] [Cited by in Crossref: 40] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
446 Kobayashi H, Espinosa R, Fernald AA, Begy C, Diaz MO, Beau MML, Rowley JD. Analysis of deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization. Genes Chromosom Cancer 1993;8:246-52. [DOI: 10.1002/gcc.2870080407] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
447 Trosko JE. Hierarchical and cybernetic nature of biologic systems and their relevance to homeostatic adaptation to low-level exposures to oxidative stress-inducing agents. Environ Health Perspect 1998;106 Suppl 1:331-9. [PMID: 9539027 DOI: 10.1289/ehp.98106s1331] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
448 Reddy GP. Cell cycle: regulatory events in G1-->S transition of mammalian cells. J Cell Biochem 1994;54:379-86. [PMID: 8014186 DOI: 10.1002/jcb.240540404] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 2.0] [Reference Citation Analysis]
449 Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin N, Prochownik EV. Mutation of the MXI1 gene in prostate cancer. Nat Genet 1995;9:249-55. [DOI: 10.1038/ng0395-249] [Cited by in Crossref: 134] [Cited by in F6Publishing: 118] [Article Influence: 5.2] [Reference Citation Analysis]
450 Calin GA, Croce CM. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 2007;117:2059-66. [PMID: 17671640 DOI: 10.1172/JCI32577] [Cited by in Crossref: 120] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
451 Duesberg PH, Schwartz JR. Latent viruses and mutated oncogenes: no evidence for pathogenicity. Prog Nucleic Acid Res Mol Biol 1992;43:135-204. [PMID: 1410445 DOI: 10.1016/s0079-6603(08)61047-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
452 Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer. 2002;2:910-917. [PMID: 12459729 DOI: 10.1038/nrc950] [Cited by in Crossref: 473] [Cited by in F6Publishing: 406] [Article Influence: 26.3] [Reference Citation Analysis]
453 Ham S, Schraffordt Koops H, van der Graaf W, van Horn J, Postma L, Hoekstra H. Historical, current and future aspects of osteosarcoma treatment. European Journal of Surgical Oncology (EJSO) 1998;24:584-600. [DOI: 10.1016/s0748-7983(98)93896-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
454 Ludwig C, Gencik M, Shipman R. Multistep transformation in low-grade lymphoproliferative diseases. Annals of Oncology 1993;4:825-30. [DOI: 10.1093/oxfordjournals.annonc.a058387] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
455 Leggett B, Young J, Buttenshaw R, Thomas L, Young B, Chenevix-Trench G, Searle J, Ward M. Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. Br J Cancer 1995;71:1070-3. [PMID: 7734302 DOI: 10.1038/bjc.1995.206] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
456 Hagemeier C, Cook A, Kouzarides T. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res 1993;21:4998-5004. [PMID: 8255752 DOI: 10.1093/nar/21.22.4998] [Cited by in Crossref: 83] [Cited by in F6Publishing: 100] [Article Influence: 3.1] [Reference Citation Analysis]
457 Wakabayashi Y, Inoue J, Takahashi Y, Matsuki A, Kosugi-Okano H, Shinbo T, Mishima Y, Niwa O, Kominami R. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 2003;301:598-603. [PMID: 12565905 DOI: 10.1016/s0006-291x(02)03069-3] [Cited by in Crossref: 87] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
458 Sakorafas GH, Tsiotou AG, Tsiotos GG. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 2000;26:29-52. [PMID: 10660490 DOI: 10.1053/ctrv.1999.0144] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
459 Sengstag C. The Role of Mitotic Recombination in Carcinogenesis. Critical Reviews in Toxicology 2008;24:323-53. [DOI: 10.3109/10408449409017922] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
460 Naderi S, Blomhoff HK. Retinoic Acid Prevents Phosphorylation of pRB in Normal Human B Lymphocytes: Regulation of Cyclin E, Cyclin A, and p21Cip1. Blood 1999;94:1348-58. [DOI: 10.1182/blood.v94.4.1348] [Cited by in Crossref: 38] [Article Influence: 1.7] [Reference Citation Analysis]
461 Siegfried JM, Hunt JD, Zhou J, Keller SM, Testa JR. Cytogenetic abnormalities in non-small cell lung carcinoma: Similarity of findings in conventional and feeder cell layer cultures. Genes Chromosom Cancer 1993;6:30-8. [DOI: 10.1002/gcc.2870060107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
462 van Driel WJ, Kenter GG, Fleuren GJ, Melief CJ, Trimbos BJ. Immunotherapeutic strategies for cervical squamous carcinoma. Hematol Oncol Clin North Am 1999;13:259-73. [PMID: 10080080 DOI: 10.1016/s0889-8588(05)70164-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
463 Lanfrancone L, Pelicci G, Pelicci PG. Cancer genetics. Current Opinion in Genetics & Development 1994;4:109-19. [DOI: 10.1016/0959-437x(94)90099-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
464 Nakagami H, Sekine M, Murakami H, Shinmyo A. Tobacco retinoblastoma-related protein phosphorylated by a distinct cyclin-dependent kinase complex with Cdc2/cyclin D in vitro. Plant J 1999;18:243-52. [PMID: 10377991 DOI: 10.1046/j.1365-313x.1999.00449.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
465 Habuchi T, Ogawa O, Kakehi Y, Ogura K, Koshiba M, Hamazaki S, Takahashi R, Sugiyama T, Yoshida O. Accumulated allelic losses in the development of invasive urothelial cancer. Int J Cancer 1993;53:579-84. [DOI: 10.1002/ijc.2910530409] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 2.7] [Reference Citation Analysis]
466 Ikezu T, Okamoto T, Murayama Y, Okamoto T, Homma Y, Ogata E, Nishimoto I. Bidirectional regulation of c-fos promoter by an oncogenic gip2 mutant of G alpha i2. A novel implication of retinoblastoma gene product. Journal of Biological Chemistry 1994;269:31955-61. [DOI: 10.1016/s0021-9258(18)31788-5] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
467 Kratzke R, Otterson G, Lin A, Shimizu E, Alexandrova N, Zajac-kaye M, Horowitz J, Kaye F. Functional analysis at the Cys706 residue of the retinoblastoma protein. Journal of Biological Chemistry 1992;267:25998-6003. [DOI: 10.1016/s0021-9258(18)35707-7] [Cited by in Crossref: 17] [Article Influence: 0.6] [Reference Citation Analysis]
468 Lin D, Fiscella M, O'Connor PM, Jackman J, Chen M, Luo LL, Sala A, Travali S, Appella E, Mercer WE. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. Proc Natl Acad Sci U S A 1994;91:10079-83. [PMID: 7937841 DOI: 10.1073/pnas.91.21.10079] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 2.8] [Reference Citation Analysis]
469 Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A, Ogoshi S. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer. 1998;77:92-97. [PMID: 9459151 DOI: 10.1038/bjc.1998.14] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
470 Zidan J, Sikorsky N, Basher W, Sharabi A, Friedman E, Steiner M. Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel. Int J Cancer 2012;131:924-9. [DOI: 10.1002/ijc.26431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
471 Schneider BL, Kulesz-Martin M, Bowden GT. Induced terminal differentiation and tumorigenic suppression in murine keratinocyte somatic-cell hybrids. Mol Carcinog 1995;13:6-14. [PMID: 7766311 DOI: 10.1002/mc.2940130103] [Reference Citation Analysis]
472 O'brian CA, Ward NE, loannides CG. Altered Signal Transduction in Carcinogenesis1. Biology of the Cancer Cell. Elsevier; 1993. pp. 61-88. [DOI: 10.1016/s1569-2558(08)60235-0] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
473 Fujikawa Y, Ishikawa-Fujiwara T, Kuo T, Shinkai N, Shoji T, Kawasaki T, Kamei Y, Sakuraba Y, Sato A, Kinoshita M, Gondo Y, Yuba S, Tsujimura T, Sese J, Todo T. Involvement of Rev1 in alkylating agent-induced loss of heterozygosity in Oryzias latipes. Genes Cells 2020;25:124-38. [PMID: 31917895 DOI: 10.1111/gtc.12746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
474 . Molecular pathology of sporadic pituitary tumors. Endocr Pathol 1993;4:175-7. [DOI: 10.1007/bf02915459] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
475 Tawn EJ. Chromosome changes in human cancer—are they pointers to mechanisms of initiation? Radiat Oncol Investig 1997;5:97-102. [DOI: 10.1002/(sici)1520-6823(1997)5:3<97::aid-roi2>3.0.co;2-d] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
476 Tonini G, Pantano F, Vincenzi B, Gabbrielli A, Coppola R, Santini D. Molecular prognostic factors in patients with pancreatic cancer. Expert Opinion on Therapeutic Targets 2007;11:1553-69. [DOI: 10.1517/14728222.11.12.1553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
477 Taylor BS, Ladanyi M. Clinical cancer genomics: how soon is now? J Pathol 2011;223:319-27. [DOI: 10.1002/path.2794] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
478 Schirmacher P, Rogler CE, Dienes HP. Current pathogenetic and molecular concepts in viral liver carcinogenesis. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;63:71-89. [PMID: 8094924 DOI: 10.1007/BF02899246] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
479 Merlino G. Transgenic Mice as Models for Tumorigenesis. Cancer Investigation 2009;12:203-13. [DOI: 10.3109/07357909409024875] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
480 Mccormick F, Myers P. From genetics to chemistry: tumor suppressor genes and drug discovery. Chemistry & Biology 1994;1:7-9. [DOI: 10.1016/1074-5521(94)90035-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
481 Berczi I, Baragar FD, Chalmers IM, Keystone EC, Nagy E, Warrington RJ. Hormones in self Tolerance and Autoimmunity: A role in the Pathogenesis of Rheumatoid Arthritis? Autoimmunity 2009;16:45-56. [DOI: 10.3109/08916939309010647] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
482 Wen SF, Nodelman M, Nared-hood K, Duncan J, Geradts J, Shepard H. Retinoblastoma protein monoclonal antibodies with novel characteristics. Journal of Immunological Methods 1994;169:231-40. [DOI: 10.1016/0022-1759(94)90267-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
483 Bhat RV, Axt KJ, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler KW, Baraban JM. Expression of the APC tumor suppressor protein in oligodendroglia. Glia 1996;17:169-74. [PMID: 8776583 DOI: 10.1002/(SICI)1098-1136(199606)17:2<169::AID-GLIA8>3.0.CO;2-Y] [Cited by in Crossref: 168] [Cited by in F6Publishing: 99] [Article Influence: 6.7] [Reference Citation Analysis]
484 Low KG, Chu HM, Schwartz PM, Daniels GM, Melner MH, Comb MJ. Novel interactions between human T-cell leukemia virus type I Tax and activating transcription factor 3 at a cyclic AMP-responsive element. Mol Cell Biol 1994;14:4958-74. [PMID: 8007991 DOI: 10.1128/mcb.14.7.4958-4974.1994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
485 Hidekiishikura, Yufu Y, Yamashita S, Abe Y, Okamura T, Motomura S, Nishimura J, Nawata H. Biphenotypic Blast Crisis of Chronic Myelogenous Leukemia: Abnormalities of p53 and Retinoblastoma Genes. Leukemia & Lymphoma 2009;25:573-8. [DOI: 10.3109/10428199709039046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
486 Seth A, Gupta S, Davis RJ. Cell cycle regulation of the c-Myc transcriptional activation domain. Mol Cell Biol 1993;13:4125-36. [PMID: 8321217 DOI: 10.1128/mcb.13.7.4125-4136.1993] [Cited by in Crossref: 57] [Article Influence: 2.0] [Reference Citation Analysis]
487 Adnane J, Shao Z, Robbins PD. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem. 1995;270:8837-8843. [PMID: 7721791 DOI: 10.1074/jbc.270.15.8837] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 2.7] [Reference Citation Analysis]
488 Massagué J. Receptors for the TGF-beta family. Cell. 1992;69:1067-1070. [PMID: 1319842 DOI: 10.1016/0092-8674(92)90627-o] [Cited by in Crossref: 476] [Cited by in F6Publishing: 108] [Article Influence: 16.4] [Reference Citation Analysis]
489 Mori N, Morosetti R, Lee S, Spira S, Ben-yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP. Allelotype Analysis in the Evolution of Chronic Myelocytic Leukemia. Blood 1997;90:2010-4. [DOI: 10.1182/blood.v90.5.2010] [Cited by in Crossref: 38] [Article Influence: 1.6] [Reference Citation Analysis]
490 Snow ET. Metal carcinogenesis: Mechanistic implications. Pharmacology & Therapeutics 1992;53:31-65. [DOI: 10.1016/0163-7258(92)90043-y] [Cited by in Crossref: 229] [Cited by in F6Publishing: 38] [Article Influence: 7.9] [Reference Citation Analysis]
491 Shin SM, Chung YJ, Oh ST, Jeon HM, Hwang LJ, Namkoong H, Kim HK, Cho GW, Hur SY, Kim TE. HCCR-1-interacting molecule & quot; deleted in polyposis 1& quot; plays a tumor-suppressor role in colon carcinogenesis. Gastroenterology. 2006;130:2074-2086. [PMID: 16762630 DOI: 10.1053/j.gastro.2006.03.055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
492 Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes Dev. 2012;26:1268-1286. [PMID: 22713868 DOI: 10.1101/gad.190678.112] [Cited by in Crossref: 721] [Cited by in F6Publishing: 620] [Article Influence: 80.1] [Reference Citation Analysis]
493 Shah S, Brock EJ, Jackson RM, Ji K, Boerner JL, Sloane BF, Mattingly RR. Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation. Neoplasia 2018;20:951-63. [PMID: 30144784 DOI: 10.1016/j.neo.2018.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
494 Korkolopoulou P, Vassilopoulos I, Konstantinidou AE, Zorzos H, Patsouris E, Agapitos E, Davaris P. The combined evaluation of p27Kip1 and Ki-67 expression provides independent information on overall survival of ovarian carcinoma patients. Gynecol Oncol 2002;85:404-14. [PMID: 12051866 DOI: 10.1006/gyno.2002.6627] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
495 Tang J, Yeh S, Chen P, Lin M, Tien H, Chen Y. Inactivation of the retinoblastoma gene in acute myelogenous leukaemia. Br J Haematol 1992;82:502-7. [DOI: 10.1111/j.1365-2141.1992.tb06459.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
496 Lin Y, Chan SH. Cloning and characterization of two processed p53 pseudogenes from the rat genome. Gene. 1995;156:183-189. [PMID: 7758955 DOI: 10.1016/0378-1119(95)00015-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
497 Dursun G, Sak SD, Akyol G, Dursun A, Erekul S, Demireller A, Akiner M. Overexpression of p53 in Laryngeal Carcinoma: Clinicopathological Implications. Ear Nose Throat J 1995;74:645-8. [DOI: 10.1177/014556139507400911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
498 Siegert JL, Robbins PD. Rb inhibits the intrinsic kinase activity of TATA-binding protein-associated factor TAFII250. Mol Cell Biol 1999;19:846-54. [PMID: 9858607 DOI: 10.1128/MCB.19.1.846] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
499 Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 2002;16:327-34. [PMID: 11896535 DOI: 10.1038/sj.leu.2402389] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 3.7] [Reference Citation Analysis]
500 van Driei WJ, Ressing ME, Brandt RMP, Toes REM, Fleuren GJ, Trimbos JB, Kast WM, Melief CJM. The Current Status of Therapeutic HPV Vaccine. Annals of Medicine 2009;28:471-7. [DOI: 10.3109/07853899608999110] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
501 Lin MH, Hsieh SC, Li SY, Shih HC, Chiang T, McBride J, Todd R, Chou LS, Chou MY, Wong DT. Sequential cytogenetic alterations in hamster oral keratinocytes during DMBA-induced oral carcinogenesis. Eur J Cancer B Oral Oncol 1994;30B:252-64. [PMID: 7950840 DOI: 10.1016/0964-1955(94)90007-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
502 Rom W, Hay J, Lee T, Jiang Y, Tchou-wong K. Molecular and Genetic Aspects of Lung Cancer. Am J Respir Crit Care Med 2000;161:1355-67. [DOI: 10.1164/ajrccm.161.4.9908012] [Cited by in Crossref: 102] [Cited by in F6Publishing: 74] [Article Influence: 4.9] [Reference Citation Analysis]
503 Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJ. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci U S A 1993;90:1013-7. [PMID: 8430068 DOI: 10.1073/pnas.90.3.1013] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 3.6] [Reference Citation Analysis]
504 Salnikow K, Cosentino S, Klein C, Costa M. Loss of thrombospondin transcriptional activity in nickel-transformed cells. Mol Cell Biol 1994;14:851-8. [PMID: 8264652 DOI: 10.1128/mcb.14.1.851-858.1994] [Cited by in Crossref: 42] [Article Influence: 1.6] [Reference Citation Analysis]
505 Pradhan S, Kim GD. The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activity. EMBO J 2002;21:779-88. [PMID: 11847125 DOI: 10.1093/emboj/21.4.779] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 4.3] [Reference Citation Analysis]
506 Piepkorn MW. Genetic basis of susceptibility to melanoma. Journal of the American Academy of Dermatology 1994;31:1022-39. [DOI: 10.1016/s0190-9622(94)70274-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
507 Heenatigala Palliyage G, Singh S, Ashby CR Jr, Tiwari AK, Chauhan H. Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma. AAPS PharmSciTech 2019;20:250. [PMID: 31297635 DOI: 10.1208/s12249-019-1457-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
508 Rao SS, Chu C, Kohtz DS. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol Cell Biol 1994;14:5259-67. [PMID: 8035804 DOI: 10.1128/mcb.14.8.5259-5267.1994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 55] [Article Influence: 0.1] [Reference Citation Analysis]
509 Scharovsky OG, Rozados VR, Gervasoni SI, Matar P. Inhibition of ras oncogene: a novel approach to antineoplastic therapy. J Biomed Sci 2000;7:292-8. [PMID: 10895051 DOI: 10.1007/BF02253247] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
510 Nakayama K, Nakayama K. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays 1998;20:1020-9. [DOI: 10.1002/(sici)1521-1878(199812)20:12<1020::aid-bies8>3.0.co;2-d] [Cited by in Crossref: 88] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
511 Taya Y. RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci 1997;22:14-7. [PMID: 9020586 DOI: 10.1016/s0968-0004(96)10070-0] [Cited by in Crossref: 160] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
512 Rebollo A, Schmitt C. Ikaros, Aiolos and Helios: Transcription regulators and lymphoid malignancies. Immunol Cell Biol 2003;81:171-5. [DOI: 10.1046/j.1440-1711.2003.01159.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
513 Leon JA, Goldstein NI, Fisher PB. New approaches for the development and application of monoclonal antibodies for the diagnosis and therapy of human cancer. Pharmacology & Therapeutics 1994;61:237-78. [DOI: 10.1016/0163-7258(94)90065-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
514 Cui Y, Mirkia K, Florence Fu Y, Zhu L, Yokoyama KK, Chiu R. Interaction of the retinoblastoma gene product, RB, with cyclophilin A negatively affects cyclosporin-inhibited NFAT signaling. J Cell Biochem 2002;86:630-41. [DOI: 10.1002/jcb.10253] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
515 Scheffler J, Waugh D, Bekesi E, Kiefer S, Losardo J, Neri A, Prinzo K, Tsao K, Wegrzynski B, Emerson S. Characterization of a 78-residue fragment of c-Raf-1 that comprises a minimal binding domain for the interaction with Ras-GTP. Journal of Biological Chemistry 1994;269:22340-6. [DOI: 10.1016/s0021-9258(17)31795-7] [Cited by in Crossref: 39] [Article Influence: 1.4] [Reference Citation Analysis]
516 Ding SF, Delhanty JD, Bowles L, Dooley JS, Wood CB, Habib NA. Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma. Br J Cancer. 1993;67:1007-1010. [PMID: 8388228 DOI: 10.1038/bjc.1993.184] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
517 Contegiacomo A, Pizzi C, De Marchis L, Alimandi M, Delrio P, Di Palma E, Petrella G, Ottini L, French D, Frati L. High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers. Int J Cancer 1995;61:1-6. [PMID: 7705920 DOI: 10.1002/ijc.2910610102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
518 Wang LQ, Kwong YL, Wong KF, Kho CS, Jin DY, Tse E, Rosèn A, Chim CS. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. J Transl Med. 2014;12:52. [PMID: 24559316 DOI: 10.1186/1479-5876-12-52] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
519 Alghamdi M, Monies D, Alsohime F, Temsah H, Almodaihsh F, Aldawasri M, Alsultan A, Alkuraya FS. Implications of mosaicism in variant interpretation: A case of a de novo homozygous NF1 variant. Eur J Med Genet 2021;64:104236. [PMID: 33965620 DOI: 10.1016/j.ejmg.2021.104236] [Reference Citation Analysis]
520 Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer 1993;72:1171-7. [PMID: 8339210 DOI: 10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d] [Cited by in Crossref: 175] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
521 Pavao M, Huang YH, Hafer LJ, Moreland RB, Traish AM. Immunodetection of nmt55/p54nrb isoforms in human breast cancer. BMC Cancer. 2001;1:15. [PMID: 11710964 DOI: 10.1186/1471-2407-1-15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
522 Wang DX, Fang DC, Luo YH, Liu WW. Loss of heterozygosity and mRNA expression at deleted in colorectal cancer gene locus in gastric cancer. World J Gastroenterol 1997;3:156-9. [PMID: 27239131 DOI: 10.3748/wjg.v3.i3.156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
523 Smith ML, Lombardi B, Chandar N. Low frequency of retinoblastoma gene alterations in rat hepatocellular carcinomas. Mol Carcinog 1993;8:228-33. [DOI: 10.1002/mc.2940080405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
524 Tripputi P, Cassani B, Alfano R, Graziani D, Cigognini D, Doi P, Bignotto M, Corneo G, Coggi G. Chromosome 7 monosomy and deletions in myeloproliferative diseases. Leukemia Research 2001;25:735-9. [DOI: 10.1016/s0145-2126(01)00012-1] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
525 Temperani P, Luppi M, Giacobbi F, Medici V, Morselli M, Barozzi P, Marasca R, Torelli G, Emilia G. Late-Appearing PML/RARα Fusion Transcript with Coincidental t(12;13)(p13.2;q14) in Acute Promyelocytic Leukemia Lacking the t(15;17) Cytogenetic Anomaly. Cancer Genetics and Cytogenetics 2000;119:121-6. [DOI: 10.1016/s0165-4608(99)00233-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
526 Abdollahi A, Gruver BN, Patriotis C, Hamilton TC. Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells. Biochem Biophys Res Commun 2003;307:188-97. [PMID: 12849999 DOI: 10.1016/s0006-291x(03)01140-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
527 Lin SR, Yang YC, Jung JH, Tsai JH. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors. DNA Cell Biol 1996;15:793-803. [PMID: 8892752 DOI: 10.1089/dna.1996.15.793] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
528 Slack RS, Miller FD. Retinoblastoma gene in mouse neural development. Dev Genet 1996;18:81-91. [DOI: 10.1002/(sici)1520-6408(1996)18:1<81::aid-dvg9>3.0.co;2-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
529 Groves N, Baird PN, Hogg A, Cowell JK. A single base pair polymorphism in the WT1 gene detected by single-strand conformation polymorphism analysis. Hum Genet 1992;90:440-2. [PMID: 1483703 DOI: 10.1007/BF00220474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
530 Edwards G, Huber H, Defeo-jones D, Vuocolo G, Goodhart P, Maigetter R, Sanyal G, Oliff A, Heimbrook D. Purification and characterization of a functionally homogeneous 60-kDa species of the retinoblastoma gene product. Journal of Biological Chemistry 1992;267:7971-4. [DOI: 10.1016/s0021-9258(18)42393-9] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
531 Helin K, Harlow E, Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993;13:6501-8. [PMID: 8413249 DOI: 10.1128/mcb.13.10.6501-6508.1993] [Cited by in Crossref: 255] [Article Influence: 9.1] [Reference Citation Analysis]
532 Wiestler OD, Brüstle O, Eibl RH, Radner H, Deimling AV, Plate K, Aguzzi A, Kleihues P. A new approach to the molecular basis of neoplastic transformation in the brain. Neuropathol Appl Neurobiol 1992;18:443-53. [DOI: 10.1111/j.1365-2990.1992.tb00810.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
533 Nishikawa S, Ishii H, Haraguchi N, Kano Y, Fukusumi T, Ohta K, Ozaki M, Dewi DL, Sakai D, Satoh T, Nagano H, Doki Y, Mori M. microRNA-based cancer cell reprogramming technology. Exp Ther Med 2012;4:8-14. [PMID: 23060915 DOI: 10.3892/etm.2012.558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
534 Tennant RW. A perspective on nonmutagenic mechanisms in carcinogenesis. Environ Health Perspect 1993;101 Suppl 3:231-6. [PMID: 8143623 DOI: 10.1289/ehp.93101s3231] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
535 Mendelsohn J. Personalizing oncology: perspectives and prospects. J Clin Oncol. 2013;31:1904-1911. [PMID: 23589547 DOI: 10.1200/jco.2012.45.3605] [Cited by in Crossref: 104] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
536 Habib N, Salama H, Abd El Latif Abu Median A, Isac Anis I, Abd Al Aziz RA, Sarraf C, Mitry R, Havlik R, Seth P, Hartwigsen J. Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Ther. 2002;9:254-259. [PMID: 11896441 DOI: 10.1038/sj.cgt.7700431] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 4.5] [Reference Citation Analysis]
537 Silletti S, Raz A. Regulation of Autocrine Motility Factor Receptor Expression in Tumor Cell Locomotion and Metastasis. In: Günthert U, Birchmeier W, editors. Attempts to Understand Metastasis Formation II. Berlin: Springer Berlin Heidelberg; 1996. pp. 137-69. [DOI: 10.1007/978-3-642-61109-4_7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
538 Starostik P, Chow KN, Dean DC. Transcriptional repression and growth suppression by the p107 pocket protein. Mol Cell Biol 1996;16:3606-14. [PMID: 8668177 DOI: 10.1128/MCB.16.7.3606] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
539 Ruggieri M, Upadhyaya M, Rocco CD, Gabriele A, Pascual-castroviejo I. Neurofibromatosis type 1 & Related Disorders. In: Ruggieri M, Pascual-castroviejo I, Di Rocco C, editors. Neurocutaneous Disorders Phakomatoses and Hamartoneoplastic Syndromes. Vienna: Springer; 2008. pp. 51-151. [DOI: 10.1007/978-3-211-69500-5_3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
540 Fong KM, Zimmerman PV, Smith PJ. Lung pathology: the molecular genetics of non-small cell lung cancer. Pathology 1995;27:295-301. [DOI: 10.1080/00313029500169173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
541 Woitach JT, Zhang M, Niu C, Thorgeirsson SS. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Nat Genet 1998;19:371-4. [DOI: 10.1038/1258] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
542 Funk SE, Sage EH. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol 1993;154:53-63. [PMID: 8419407 DOI: 10.1002/jcp.1041540108] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 3.4] [Reference Citation Analysis]
543 Warnakulasuriya KAAS, Johnson NW. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med 1994;23:246-50. [DOI: 10.1111/j.1600-0714.1994.tb00053.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 1.3] [Reference Citation Analysis]
544 Varghese C, Nair S, Panikkar B, Panikkar K. Effect of asoka on the intracellular glutathione levels and skin tumour promotion in mice. Cancer Letters 1993;69:45-50. [DOI: 10.1016/0304-3835(93)90031-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
545 Fan Z, Lu Y, Wu X, DeBlasio A, Koff A, Mendelsohn J. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J Cell Biol. 1995;131:235-242. [PMID: 7559780 DOI: 10.1083/jcb.131.1.235] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 3.3] [Reference Citation Analysis]
546 Minobe K, Bando K, Fukino K, Soma S, Kasumi F, Sakamoto G, Furukawa K, Higuchi K, Onda M, Nakamura Y, Emi M. Somatic mutation of the PTEN/MMAC1 gene in breast cancers with microsatellite instability. Cancer Letters 1999;144:9-16. [DOI: 10.1016/s0304-3835(99)00181-0] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
547 Levine AJ, Hu W, Feng Z. Tumor Suppressor Genes. The Molecular Basis of Cancer. Elsevier; 2008. pp. 31-8. [DOI: 10.1016/b978-141603703-3.10003-2] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
548 Gao X, Honn KV. Chapter 5 Molecular biology of prostate cancer. The Oncobiology of the Prostate. Elsevier; 1999. pp. 85-122. [DOI: 10.1016/s1569-254x(99)80006-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
549 Shannon KM, Le Beau MM. Cancer: hay in a haystack. Nature 2008;451:252-3. [PMID: 18202630 DOI: 10.1038/451252a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
550 Weston A, Godbold JH. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. Environ Health Perspect 1997;105 Suppl 4:919-26. [PMID: 9255581 DOI: 10.1289/ehp.97105s4919] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 1.8] [Reference Citation Analysis]
551 Habib R. Nephrotic syndrome in the 1st year of life. Pediatr Nephrol 1993;7:347-53. [DOI: 10.1007/bf00857534] [Cited by in Crossref: 69] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
552 Manuelidis L. Genomic stability and instability in different neuroepithelial tumors. A role for chromosome structure? J Neurooncol 1994;18:225-39. [PMID: 7964983 DOI: 10.1007/BF01328957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
553 Roth JA, Mukhopadhyay T, Zhang W, Fujiwara T, Georges R. Gene replacement strategies for lung cancer. Seminars in Radiation Oncology 1996;6:105-9. [DOI: 10.1016/s1053-4296(96)80007-5] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
554 Pushkareva M, Obeid LM, Hannun YA. Ceramide: an endogenous regulator of apoptosis and growth suppresion. Immunology Today 1995;16:294-7. [DOI: 10.1016/0167-5699(95)80184-7] [Cited by in Crossref: 134] [Cited by in F6Publishing: 118] [Article Influence: 5.2] [Reference Citation Analysis]
555 Rouault JP, Samarut C, Duret L, Tessa C, Samarut J, Magaud JP. Sequence analysis reveals that the BTG1 anti-proliferative gene is conserved throughout evolution in its coding and 3' non-coding regions. Gene 1993;129:303-6. [PMID: 8325512 DOI: 10.1016/0378-1119(93)90284-a] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
556 Adam SJ, Rund LA, Kuzmuk KN, Zachary JF, Schook LB, Counter CM. Genetic induction of tumorigenesis in swine. Oncogene 2007;26:1038-45. [PMID: 16964292 DOI: 10.1038/sj.onc.1209892] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
557 Mujoo, Catino, Maneval, Gutterman. Studies on the molecular mechanism of growth inhibition with p53 adenoviral construct in human ovarian cancer. Int J Gynecol Cancer 1998;8:233-41. [DOI: 10.1046/j.1525-1438.1998.09834.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
558 Tawn EJ. Leukaemia and Sellafield: is there a heritable link? J Med Genet 1995;32:251-6. [PMID: 7643351 DOI: 10.1136/jmg.32.4.251] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
559 Hoppe-Seyler F, Butz K. Tumor suppressor genes in molecular medicine. Clin Investig. 1994;72:619-630. [PMID: 7819720 DOI: 10.1007/bf00227456] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
560 Kralj M, Husnjak K, Körbler T, Pavelić J. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression. Cancer Gene Ther 2003;10:457-67. [PMID: 12768191 DOI: 10.1038/sj.cgt.7700588] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
561 Yu L, Issaq HJ, Veenstra TD. Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets. Prot Clin Appl 2007;1:1042-57. [DOI: 10.1002/prca.200700102] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
562 Richie ER, Schumacher A, Angel JM, Holloway M, Rinchik EM, Magnuson T. The Polycomb-group gene eed regulates thymocyte differentiation and suppresses the development of carcinogen-induced T-cell lymphomas. Oncogene 2002;21:299-306. [PMID: 11803473 DOI: 10.1038/sj.onc.1205051] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
563 Huang JS, Chiang CP, Kok SH, Kuo YS, Kuo MY. Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1997;26:322-6. [PMID: 9250932 DOI: 10.1111/j.1600-0714.1997.tb00223.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
564 Mercadé E, Cascalló M, Carrió M, Calbó J, Gómez-treviño A, Fillat C, Gómez-foix A, Mazo A. Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer. Annals of Oncology 2001;12:379-88. [DOI: 10.1023/a:1011177223129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
565 Mohapatra G, Kim DH, Feuerstein BG. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosom Cancer 1995;13:86-93. [DOI: 10.1002/gcc.2870130203] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 2.3] [Reference Citation Analysis]
566 Michor F. Chromosomal instability and human cancer. Philos Trans R Soc Lond B Biol Sci 2005;360:631-5. [PMID: 15897185 DOI: 10.1098/rstb.2004.1617] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
567 Ko SC, Gotoh A, Thalmann GN, Zhau HE, Johnston DA, Zhang WW, Kao C, Chung LW. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Hum Gene Ther 1996;7:1683-91. [PMID: 8886839 DOI: 10.1089/hum.1996.7.14-1683] [Cited by in Crossref: 86] [Cited by in F6Publishing: 65] [Article Influence: 3.6] [Reference Citation Analysis]
568 Chan AM, Fleming TP, McGovern ES, Chedid M, Miki T, Aaronson SA. Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Mol Cell Biol 1993;13:762-8. [PMID: 8423800 DOI: 10.1128/mcb.13.2.762-768.1993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 39] [Article Influence: 0.0] [Reference Citation Analysis]
569 Woodward TL, Dumont N, O'Connor-McCourt M, Turner JD, Philip A. Characterization of transforming growth factor-beta growth regulatory effects and receptors on bovine mammary cells. J Cell Physiol 1995;165:339-48. [PMID: 7593212 DOI: 10.1002/jcp.1041650215] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
570 Kojima A, Maeda H, Sugita Y, Tanaka S, Kameyama Y. Human papillomavirus type 38 infection in oral squamous cell carcinomas. Oral Oncology 2002;38:591-6. [DOI: 10.1016/s1368-8375(01)00112-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
571 Killary AM, Wolf ME, Giambernardi TA, Naylor SL. Definition of a tumor suppressor locus within human chromosome 3p21-p22. Proc Natl Acad Sci U S A 1992;89:10877-81. [PMID: 1438292 DOI: 10.1073/pnas.89.22.10877] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 2.8] [Reference Citation Analysis]
572 Peiró G, Diebold J, Löhrs U. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. Am J Clin Pathol. 2002;118:922-929. [PMID: 12472286 DOI: 10.1309/XYCB-UW8U-5541-U4QD] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
573 Medema RH, Herrera RE, Lam F, Weinberg RA. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A 1995;92:6289-93. [PMID: 7603984 DOI: 10.1073/pnas.92.14.6289] [Cited by in Crossref: 267] [Cited by in F6Publishing: 277] [Article Influence: 10.3] [Reference Citation Analysis]
574 Demers GW, Foster SA, Halbert CL, Galloway DA. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA. 1994;91:4382-4386. [PMID: 8183918 DOI: 10.1073/pnas.91.10.4382] [Cited by in Crossref: 146] [Cited by in F6Publishing: 154] [Article Influence: 5.4] [Reference Citation Analysis]
575 Ezzat S, Zheng L, Kolenda J, Safarian A, Freeman JL, Asa SL. Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid 1996;6:409-16. [PMID: 8936664 DOI: 10.1089/thy.1996.6.409] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 3.2] [Reference Citation Analysis]
576 Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K, Croce CM. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol. 2002;3:748-754. [PMID: 12473516 DOI: 10.1016/s1470-2045(02)00931-2] [Cited by in Crossref: 82] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
577 Okano H, Saito Y, Miyazawa T, Shinbo T, Chou D, Kosugi S, Takahashi Y, Odani S, Niwa O, Kominami R. Homozygous deletions and point mutations of the Ikaros gene in gamma-ray-induced mouse thymic lymphomas. Oncogene 1999;18:6677-83. [PMID: 10597273 DOI: 10.1038/sj.onc.1203100] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]
578 Lee SW, Wei JY. Molecular Interactions of Aging and Cancer. Clinics in Geriatric Medicine 1997;13:69-77. [DOI: 10.1016/s0749-0690(18)30183-6] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
579 Smith ML, Yeleswarapu L, Lombardi B, Shinozuka H. Lack of mutations of thep53 tumor suppressor gene in hepatocellular carcinomas induced in rats by a peroxisome proliferator. Mol Carcinog 1993;7:89-93. [DOI: 10.1002/mc.2940070206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
580 Gong Y, He T, Yang L, Yang G, Chen Y, Zhang X. The role of miR-100 in regulating apoptosis of breast cancer cells. Sci Rep 2015;5:11650. [PMID: 26130569 DOI: 10.1038/srep11650] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 8.3] [Reference Citation Analysis]
581 Hatta Y, Yamada Y, Tomonaga M, Miyoshi I, Said JW, Koeffler HP. Detailed Deletion Mapping of the Long Arm of Chromosome 6 in Adult T-Cell Leukemia. Blood 1999;93:613-6. [DOI: 10.1182/blood.v93.2.613.402k13_613_616] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
582 Timchenko NA, Wilde M, Darlington GJ. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice. Mol Cell Biol 1999;19:2936-45. [PMID: 10082561 DOI: 10.1128/MCB.19.4.2936] [Cited by in Crossref: 77] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
583 Boyanapalli M, Lahoud OB, Messiaen L, Kim B, Anderle de Sylor MS, Duckett SJ, Somara S, Mikol DD. Neurofibromin binds to caveolin-1 and regulates ras, FAK, and Akt. Biochem Biophys Res Commun 2006;340:1200-8. [PMID: 16405917 DOI: 10.1016/j.bbrc.2005.12.129] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
584 Sironi E, Cerri A, Tomasini D, Sirchia SM, Porta G, Rossella F, Grati FR, Simoni G. Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes: LOH in 4q32-35 in sporadic basal cell carcinomas. Journal of Cutaneous Pathology 2004;31:318-22. [DOI: 10.1111/j.0303-6987.2004.0187.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
585 Moxley AH, Reisman D. Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor. Cell Biochem Funct 2021;39:235-47. [PMID: 32996618 DOI: 10.1002/cbf.3590] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
586 Robles AI, Jen J, Harris CC. Clinical Outcomes of TP53 Mutations in Cancers. Cold Spring Harb Perspect Med 2016;6:a026294. [PMID: 27449973 DOI: 10.1101/cshperspect.a026294] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
587 Charef-hamza S, Trimeche M, Ziadi S, Amara K, Gaddas N, Mokni M, Sriha B, Yacoubi T, Korbi S. Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer. Cancer Letters 2005;224:185-91. [DOI: 10.1016/j.canlet.2004.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
588 Döhner H, Bloomfield CD, Frizzera G, Frestedt J, Arthur DC. Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosom Cancer 1992;5:392-8. [DOI: 10.1002/gcc.2870050415] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
589 Duffy M. Cellular oncogenes and suppressor genes as prognostic markers in cancer. Clinical Biochemistry 1993;26:439-47. [DOI: 10.1016/0009-9120(93)80007-h] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
590 Merlo GR, Venesio T, Bernardi A, Cropp CS, Diella F, Cappa AP, Callahan R, Liscia DS. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas. Cancer Genetics and Cytogenetics 1994;76:106-11. [DOI: 10.1016/0165-4608(94)90458-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
591 Nelson E. Laboratory Probing of Oncogenes from Human Liquid and Solid Specimens as Markers of Exposure to Toxicants. Critical Reviews in Toxicology 2008;26:483-549. [DOI: 10.3109/10408449609037476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
592 Zhou Y, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol. 2012;48:R45-R53. [PMID: 22393162 DOI: 10.1530/jme-12-0008] [Cited by in Crossref: 445] [Cited by in F6Publishing: 283] [Article Influence: 49.4] [Reference Citation Analysis]
593 Harris CC. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ Health Perspect 1996;104 Suppl 3:435-9. [PMID: 8781359 DOI: 10.1289/ehp.96104s3435] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
594 Schirrmacher V, Fournier P, Schlag P. Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function. Expert Rev Vaccines. 2014;13:117-130. [PMID: 24219122 DOI: 10.1586/14760584.2014.854169] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
595 de Juan C, Iniesta P, Vega FJ, Peinado MA, Fernandez C, Caldés T, Massa MJ, López JA, Sánchez A, Torres AJ, Balibrea JL, Benito M. Prognostic value of genomic damage in non-small-cell lung cancer. Br J Cancer 1998;77:1971-7. [PMID: 9667677 DOI: 10.1038/bjc.1998.327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
596 Simon-Kayser B, Scoul C, Renaudin K, Jezequel P, Bouchot O, Rigaud J, Bezieau S. Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma. Genes Chromosomes Cancer 2005;43:83-94. [PMID: 15723337 DOI: 10.1002/gcc.20170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
597 Nawroz-Danish HM, Koch WM, Westra WH, Yoo G, Sidransky D. Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 1998;119:21-5. [PMID: 9674510 DOI: 10.1016/S0194-5998(98)70168-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
598 Caviness VS, Takahashi T, Nowakowski RS. Cell Proliferation in Cortical Development. In: Galaburda AM, Christen Y, editors. Normal and Abnormal Development of the Cortex. Berlin: Springer Berlin Heidelberg; 1997. pp. 1-24. [DOI: 10.1007/978-3-642-60861-2_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
599 Diamandis EP. Clinical applications of tumor suppressor genes and oncogenes in cancer. Clinica Chimica Acta 1997;257:157-80. [DOI: 10.1016/s0009-8981(96)06442-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
600 Roemer K, Friedmann T. Concepts and strategies for human gene therapy. Eur J Biochem. 1992;208:211-225. [PMID: 1521521 DOI: 10.1111/j.1432-1033.1992.tb17176.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
601 Yamada M, Sofuni T, Nohmi T. Preferential induction at AT-TA transversion, but not deletions, by chlorambucil at the hisG428 site of Salmonella typhimurium TA102. Mutation Research Letters 1992;283:29-33. [DOI: 10.1016/0165-7992(92)90118-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
602 Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins VP, Dumanski JP, Rouleau GA. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994;6:180-4. [DOI: 10.1038/ng0294-180] [Cited by in Crossref: 364] [Cited by in F6Publishing: 300] [Article Influence: 13.5] [Reference Citation Analysis]
603 Kumamoto H. Molecular pathology of odontogenic tumors. J Oral Pathol Med 2006;35:65-74. [DOI: 10.1111/j.1600-0714.2006.00380.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
604 Fearon ER. DCC: Is there a connection between tumorigenesis and cell guidance molecules? Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1996;1288:M17-23. [DOI: 10.1016/0304-419x(96)00023-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
605 Naderi S, Blomhoff HK. Retinoic Acid Prevents Phosphorylation of pRB in Normal Human B Lymphocytes: Regulation of Cyclin E, Cyclin A, and p21Cip1. Blood 1999;94:1348-58. [DOI: 10.1182/blood.v94.4.1348.416k29_1348_1358] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
606 Schaapveld R, Wieringa B, Hendriks W. Receptor-like protein tyrosine phosphatases: alike and yet so different. Mol Biol Rep 1997;24:247-62. [PMID: 9403867 DOI: 10.1023/a:1006870016238] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
607 Oren M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev. 1992;11:141-148. [PMID: 1394793 DOI: 10.1007/bf00048060] [Cited by in Crossref: 62] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
608 Kulaylat MN, Dayton MT. Ulcerative colitis and cancer. J Surg Oncol. 2010;101:706-712. [PMID: 20512947 DOI: 10.1002/jso.21505] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
609 Hosal SA, Apel RL, Freeman JL, Azadian A, Rosen IB, Livolsi VA, Asa SL. Immunohistochemical localization of p53 in human thyroid neoplasms: Correlation with biological behavior. Endocr Pathol 1997;8:21-8. [DOI: 10.1007/bf02739704] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
610 Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation. Oncogene 2001;20:910-20. [DOI: 10.1038/sj.onc.1204171] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
611 Knasmüller S, Parzefall W, Helma C, Kassie F, Ecker S, Schulte-hermann R. Toxic Effects of Griseofulvin: Disease Models, Mechanisms, and Risk Assessment. Critical Reviews in Toxicology 2008;27:495-537. [DOI: 10.3109/10408449709078444] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
612 Agesen TH, Flørenes VA, Molenaar WM, Lind GE, Berner JM, Plaat BE, Komdeur R, Myklebost O, van den Berg E, Lothe RA. Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. J Neuropathol Exp Neurol 2005;64:74-81. [PMID: 15715087 DOI: 10.1093/jnen/64.1.74] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
613 Chim CS, Kwong YL, Liang R. Gene hypermethylation in multiple myeloma: lessons from a cancer pathway approach. Clin Lymphoma Myeloma 2008;8:331-9. [PMID: 19064397 DOI: 10.3816/CLM.2008.n.048] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
614 Hickman ES, Helin K. The p53 Tumour Suppressor Protein. Biotechnology and Genetic Engineering Reviews 2000;17:179-212. [DOI: 10.1080/02648725.2000.10647992] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
615 Sidransky D, Boyle J, Koch W, van der Riet P. Oncogene mutations as intermediate markers. J Cell Biochem Suppl 1993;17F:184-7. [PMID: 8412191 DOI: 10.1002/jcb.240531026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
616 Iwasa Y, Michor F, Komarova NL, Nowak MA. Population genetics of tumor suppressor genes. Journal of Theoretical Biology 2005;233:15-23. [DOI: 10.1016/j.jtbi.2004.09.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
617 Palapattu GS, Bao S, Kumar RT, Matzuk MM. Transgenic Mouse Models for Tumor Suppressor Genes. Cancer Detect Prev 1998;22:75-86. [DOI: 10.1046/j.1525-1500.1998.00012.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
618 Grigoriadis AE, Wang Z, Wagner EF. c-fos ONCOGENE EXPRESSION IN CARTILAGE AND BONE TISSUES OF TRANSGENIC AND CHIMERIC MICE. Cellular and Molecular Biology of Bone. Elsevier; 1993. pp. 497-537. [DOI: 10.1016/b978-0-08-092500-4.50019-x] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
619 Cáceres DD, Quiñones LA, Schroeder JC, Gil LD, Irarrázabal CE. Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk. Lung 2009;187:110-5. [PMID: 19129997 DOI: 10.1007/s00408-008-9133-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
620 Hannun YA, Linardic CM. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes 1993;1154:223-36. [DOI: 10.1016/0304-4157(93)90001-5] [Cited by in Crossref: 200] [Cited by in F6Publishing: 177] [Article Influence: 7.1] [Reference Citation Analysis]
621 Westbrook CA, Arenas RB. Gene therapy of the gut: introduction of the APC tumor-suppressor gene for cancer prevention or treatment. Advanced Drug Delivery Reviews 1995;17:349-55. [DOI: 10.1016/0169-409x(95)00070-n] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
622 Zenklusen JC, Oshimura M, Barrett JC, Conti CJ. Human chromosome II inhibits tumorigenicity of a murine squamous cell carcinoma cell line. Genes Chromosom Cancer 1995;13:47-53. [DOI: 10.1002/gcc.2870130108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
623 Mori N, Yang R, Kawamata N, Miller CW, Mizoguchi H, Koeffler HP. Absence of R24C Mutation of the CDK4 Gene in Leukemias and Solid Tumors. Int J Hematol 2003;77:259-62. [DOI: 10.1007/bf02983783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
624 Beijnen JH. New cytotoxic drugs and targets in oncology. Pharmaceutisch Weekblad Scientific Edition 1992;14:258-67. [DOI: 10.1007/bf01962548] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
625 Hsieh LL, Hsieh JT, Wang LY, Fang CY, Chang SH, Chen TC. p53 mutations in gastric cancers from Taiwan. Cancer Lett. 1996;100:107-113. [PMID: 8620428 DOI: 10.1016/0304-3835(95)04077-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
626 Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359:235-237. [PMID: 1528264 DOI: 10.1038/359235a0] [Cited by in Crossref: 1228] [Cited by in F6Publishing: 1109] [Article Influence: 42.3] [Reference Citation Analysis]
627 Classon M, Dyson N. p107 and p130: versatile proteins with interesting pockets. Exp Cell Res. 2001;264:135-147. [PMID: 11237530 DOI: 10.1006/excr.2000.5135] [Cited by in Crossref: 152] [Cited by in F6Publishing: 158] [Article Influence: 7.6] [Reference Citation Analysis]
628 Asamoto M, Mann AM, Macatee TL, Cohen SM. Mutations and expression of the p53 gene in rat bladder carcinomas and cell lines. Mol Carcinog 1994;9:236-44. [PMID: 8148056 DOI: 10.1002/mc.2940090408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
629 Gollin SM, Janecka IP. Cytogenetics of cranial base tumors. J Neurooncol 1994;20:241-54. [PMID: 7844621 DOI: 10.1007/BF01053042] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
630 Iannaccone PM, Zhou X, Khokha M, Boucher D, Kuehn MR. Insertional mutation of a gene involved in growth regulation of the early mouse embryo. Dev Dyn 1992;194:198-208. [DOI: 10.1002/aja.1001940305] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 5.2] [Reference Citation Analysis]
631 Sawyer JR, Swanson CM, Lukacs JL, Hassed SJ, Curtis MA, North PE, Kozlowski KJ, Pihoker C. Telomeric fusion and chromosome instability in multiple tissues of a patient with mosaic Ullrich-Turner syndrome. Am J Med Genet 1997;69:383-7. [DOI: 10.1002/(sici)1096-8628(19970414)69:4<383::aid-ajmg9>3.0.co;2-m] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
632 Shinbo T, Matsuki A, Matsumoto Y, Kosugi S, Takahashi Y, Niwa O, Kominami R. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12. Oncogene 1999;18:4131-6. [PMID: 10435594 DOI: 10.1038/sj.onc.1202767] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
633 Triantafillou NG, Grosman IM, Verma RS. Editorial: Genomania of p53 Protein in Gastric Cancer: . Journal of Clinical Gastroenterology 1996;22:170-3. [DOI: 10.1097/00004836-199604000-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
634 Kerdpon D, Rich A, Reade P. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Diseases 1997;3:86-92. [DOI: 10.1111/j.1601-0825.1997.tb00018.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
635 Chen YQ, Honn KV. Eicosanoid Regulation of Tumor Cell-Platelet and -Endothelium Interaction During Arrest and Extravasation. In: Nigam S, Honn KV, Marnett LJ, Walden TL, editors. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Boston: Springer US; 1993. pp. 613-7. [DOI: 10.1007/978-1-4615-3520-1_120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
636 Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994;17:71-91. [PMID: 7818788 DOI: 10.1016/1040-8428(94)90020-5] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 3.3] [Reference Citation Analysis]
637 Arnold A. Molecular Mechanisms of Parathyroid Neoplasia. Endocrinology and Metabolism Clinics of North America 1994;23:93-107. [DOI: 10.1016/s0889-8529(18)30118-x] [Cited by in Crossref: 15] [Article Influence: 0.6] [Reference Citation Analysis]
638 Tawn EJ, Wakeford R. Childhood Leukaemia and Radiation: The Sellafield Judgment. In: Lewins J, Becker M, editors. Advances in Nuclear Science and Technology. Boston: Kluwer Academic Publishers; 2002. pp. 1-29. [DOI: 10.1007/0-306-47812-9_1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
639 Hui A, Li X, Makuuchi, M, Takayama T, Kubota K. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma. Int J Cancer 1999;84:604-8. [DOI: 10.1002/(sici)1097-0215(19991222)84:6<604::aid-ijc11>3.0.co;2-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
640 Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE, Bowtell DD, Gorringe KL, Campbell IG. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol. 2013;229:469-476. [PMID: 23096461 DOI: 10.1002/path.4134] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 9.5] [Reference Citation Analysis]
641 Hu M, Yang J, Qu L, Deng X, Duan Z, Fu R, Liang L, Fan D. Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma. Food Funct 2020;11:456-71. [DOI: 10.1039/c9fo02166c] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 14.0] [Reference Citation Analysis]
642 De Rienzo A, Jhanwar SC, Testa JR. Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma. Genes Chromosom Cancer 2000;28:337-41. [DOI: 10.1002/1098-2264(200007)28:3<337::aid-gcc12>3.0.co;2-b] [Cited by in Crossref: 16] [Article Influence: 0.8] [Reference Citation Analysis]
643 Baffi TR, Van AN, Zhao W, Mills GB, Newton AC. Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer. Mol Cell 2019;74:378-392.e5. [PMID: 30904392 DOI: 10.1016/j.molcel.2019.02.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
644 Kasamatsu A, Uzawa K, Usukura K, Koike K, Nakashima D, Ishigami T, Fushimi K, Ogawara K, Shiiba M, Tanzawa H. Loss of heterozygosity in oral cancer. Oral Science International 2011;8:37-43. [DOI: 10.1016/s1348-8643(11)00027-9] [Cited by in Crossref: 13] [Article Influence: 1.3] [Reference Citation Analysis]
645 Wei Q, Paterson BM. Regulation of MyoD function in the dividing myoblast. FEBS Lett 2001;490:171-8. [PMID: 11223032 DOI: 10.1016/s0014-5793(01)02120-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
646 Nigg EA. Cellular substrates of p34cdc2 and its companion cyclin-dependent kinases. Trends in Cell Biology 1993;3:296-301. [DOI: 10.1016/0962-8924(93)90011-o] [Cited by in Crossref: 153] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
647 Shaham J, Bomstein Y, Melzer A, Ribak J. DNA–Protein Crosslinks and Sister Chromatid Exchanges as Biomarkers of Exposure to Formaldehyde. International Journal of Occupational and Environmental Health 2013;3:95-104. [DOI: 10.1179/107735297800407695] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
648 Cinti C, Giordano A. The retinoblastoma gene family: its role in cancer onset and progression. Emerging Therapeutic Targets 2005;4:765-83. [DOI: 10.1517/14728222.4.6.765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
649 Brandt-rauf PW, Devivo I, Dykes DC, Pincus MR. Conformational Effects Of Selected Cancer-Related Amino Acid Substitutions In The p53 Protein. Journal of Biomolecular Structure and Dynamics 1992;10:253-64. [DOI: 10.1080/07391102.1992.10508645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
650 Bidou L, Crisanti P, Blancher C, Pessac B. A novel cDNA corresponding to transcripts expressed in retina post-mitotic neurons. Mechanisms of Development 1993;43:159-73. [DOI: 10.1016/0925-4773(93)90033-t] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
651 Ju W, Park HM, Lee SN, Sung SH, Kim SC. Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma. J Obstet Gynaecol Res 2006;32:454-60. [PMID: 16984511 DOI: 10.1111/j.1447-0756.2006.00438.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
652 Moch H, Sauter G, Moore D, Mihatsch MJ, Gudat F, Waldman F. p53 anderbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer. Vichows Archiv A Pathol Anat 1993;423:329-34. [DOI: 10.1007/bf01607144] [Cited by in Crossref: 49] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
653 . Oncogenes, anti-oncogenes and the immune response to cancer : a mathematical model. Proc R Soc Lond B 1997;248:261-71. [DOI: 10.1098/rspb.1992.0071] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
654 Okada S, Tsuda H, Takarabe T, Yoshikawa H, Taketani Y, Hirohashi S. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types. Jpn J Cancer Res 2002;93:798-806. [PMID: 12149146 DOI: 10.1111/j.1349-7006.2002.tb01322.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
655 Gao P, Seebacher NA, Hornicek F, Guo Z, Duan Z. Advances in sarcoma gene mutations and therapeutic targets. Cancer Treat Rev 2018;62:98-109. [PMID: 29190505 DOI: 10.1016/j.ctrv.2017.11.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
656 Feldherr CM, Lanford RE, Akin D. Signal-mediated nuclear transport in simian virus 40-transformed cells is regulated by large tumor antigen. Proc Natl Acad Sci U S A 1992;89:11002-5. [PMID: 1279701 DOI: 10.1073/pnas.89.22.11002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 1.9] [Reference Citation Analysis]
657 Roth JA. Molecular events in lung cancer. Lung Cancer 1995;12:S3-S15. [DOI: 10.1016/s0169-5002(10)80002-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
658 Shaham J, Ribak J. The Role of Biomarkers in Detecting Early Changes Relating to Exposure to Occupational Carcinogens. Jrnl of Occup Health 2006;38:170-8. [DOI: 10.1539/joh.38.170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
659 Silver A, Moody J, Dunford R, Clark D, Ganz S, Bulman R, Bouffler S, Finnon P, Meijne E, Huiskamp R, Cox R. Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11p11-12. Genes Chromosom Cancer 1999;24:95-104. [DOI: 10.1002/(sici)1098-2264(199902)24:2<95::aid-gcc1>3.0.co;2-c] [Cited by in Crossref: 55] [Article Influence: 2.5] [Reference Citation Analysis]
660 Wakita K, Kohno N, Sakoda Y, Ishikawa Y, Sakaue M. Decreased expression of the DCC gene in human breast carcinoma. Surg Today 1996;26:900-3. [PMID: 8931221 DOI: 10.1007/BF00311792] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
661 Schmidt M, Fan Z. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells. Oncogene 2001;20:6164-71. [PMID: 11593424 DOI: 10.1038/sj.onc.1204814] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
662 Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL. Infant Cancer in the U.S.: Histology-Specific Incidence and Trends, 1973 to 1992. Journal of Pediatric Hematology/Oncology 1997;19:428-32. [DOI: 10.1097/00043426-199709000-00004] [Cited by in Crossref: 179] [Cited by in F6Publishing: 124] [Article Influence: 7.5] [Reference Citation Analysis]
663 Thakker RV, Bringhurst FR, Jüppner H. Calcium Regulation, Calcium Homeostasis, and Genetic Disorders of Calcium Metabolism. Endocrinology. Elsevier; 2010. pp. 1136-59. [DOI: 10.1016/b978-1-4160-5583-9.00060-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
664 Oberstraß J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP. MUTATION OF THE VON HIPPEL-LINDAU TUMOUR SUPPRESSOR GENE IN CAPILLARY HAEMANGIOBLASTOMAS OF THE CENTRAL NERVOUS SYSTEM. J Pathol 1996;179:151-6. [DOI: 10.1002/(sici)1096-9896(199606)179:2<151::aid-path556>3.0.co;2-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
665 Abrahams P, Schouten R, van Laar T, Houweling A, Terleth C, van der Eb A. Different regulation of p53 stability in UV-irradiated normal and DNA repair deficient human cells. Mutation Research/DNA Repair 1995;336:169-80. [DOI: 10.1016/0921-8777(94)00049-c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
666 Silva JM, Garcia JM, Dominguez G, Silva J, Miralles C, Cantos B, Coca S, Provencio M, España P, Bonilla F. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann Surg Oncol 2002;9:71-6. [PMID: 11829433 DOI: 10.1245/aso.2002.9.1.71] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
667 L�brich M, K�hne M, Wetzel J, Rothkamm K. Joining of correct and incorrect DNA double-strand break ends in normal human and ataxia telangiectasia fibroblasts. Genes Chromosom Cancer 2000;27:59-68. [DOI: 10.1002/(sici)1098-2264(200001)27:1<59::aid-gcc8>3.0.co;2-9] [Cited by in Crossref: 46] [Article Influence: 2.2] [Reference Citation Analysis]
668 Miller AC, Blakely WF, Livengood D, Whittaker T, Xu J, Ejnik JW, Hamilton MM, Parlette E, John TS, Gerstenberg HM, Hsu H. Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride. Environ Health Perspect 1998;106:465-71. [PMID: 9681973 DOI: 10.1289/ehp.98106465] [Cited by in Crossref: 103] [Cited by in F6Publishing: 71] [Article Influence: 4.5] [Reference Citation Analysis]
669 Kawasaki ES. The Polymerase Chain Reaction: Its use in the Molecular Characterization and Diagnosis of Cancers. Cancer Investigation 2009;10:417-29. [DOI: 10.3109/07357909209024799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
670 Kratz CP, Emerling BM, Bonifas J, Wang W, Green ED, Le Beau MM, Shannon KM. Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor. Blood 2002;99:372-4. [PMID: 11756194 DOI: 10.1182/blood.v99.1.372] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
671 Iatropoulos MJ. Accelerated rodent bioassay predictive of chemical carcinogenesis. Exp Toxicol Pathol 1992;44:481-7. [PMID: 1493367 DOI: 10.1016/S0940-2993(11)80161-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
672 Sarkar FH, Sakr W, Li YW, Macoska J, Ball DE, Crissman JD. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate 1992;21:145-52. [PMID: 1329054 DOI: 10.1002/pros.2990210207] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
673 Ece F, F Hatabay N, Erdal N, Gedik C, Guney C, Aksoy F. Does Helicobacter pylori infection play a role in lung cancer? Respir Med. 2005;99:1258-1262. [PMID: 16140226 DOI: 10.1016/j.rmed.2005.02.038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
674 Greenwald P, Malone WF, Cerny ME, Stern HR. Cancer Prevention Research Trials. Elsevier; 1993. pp. 1-23. [DOI: 10.1016/s0065-230x(08)60953-7] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
675 Jaurand MC. Mechanisms of fiber-induced genotoxicity. Environ Health Perspect 1997;105 Suppl 5:1073-84. [PMID: 9400703 DOI: 10.1289/ehp.97105s51073] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 3.1] [Reference Citation Analysis]
676 Tugores A, Le J, Sorokina I, Snijders AJ, Duyao M, Reddy PS, Carlee L, Ronshaugen M, Mushegian A, Watanaskul T, Chu S, Buckler A, Emtage S, McCormick MK. The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades. J Biol Chem. 2001;276:20397-20406. [PMID: 11259407 DOI: 10.1074/jbc.m010930200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
677 Kim KM, Kwon MS, Hong SJ, Min KO, Seo EJ, Lee KY, Choi SW, Rhyu MG. Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch. 2003;443:491-500. [PMID: 12920592 DOI: 10.1007/s00428-003-0840-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
678 Wynford-Thomas D. Molecular genetics of thyroid cancer. Trends Endocrinol Metab 1993;4:224-32. [PMID: 18407160 DOI: 10.1016/1043-2760(93)90126-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
679 Betzl G, Brem G, Weidle UH. Epigenetic modification of transgenes under the control of the mouse mammary tumor virus LTR: tissue-dependent influence on transcription of the transgenes. Biol Chem 1996;377:711-9. [PMID: 8960372 DOI: 10.1515/bchm3.1996.377.11.711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.0] [Reference Citation Analysis]
680 Qari MH, Khalil SH, Kambouris M, Meyer BF. Mutation of p16, p21 or cyclin dependent kinase 4 is rare in acute lymphoblastic leukaemia: Mutation of p16, p21 and CDK4 Genes in ALL. British Journal of Haematology 1998;103:467-72. [DOI: 10.1046/j.1365-2141.1998.00974.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
681 Timchenko NA, Wilde M, Iakova P, Albrecht JH, Darlington GJ. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes. Nucleic Acids Res 1999;27:3621-30. [PMID: 10446255 DOI: 10.1093/nar/27.17.3621] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
682 Kato MV, Ishizaki K, Ejima Y, Kaneko A, Tanooka H, Sasaki MS. Loss of heterozygosity on chromosome 13 and its association with delayed growth of retinoblastoma. Int J Cancer 1993;54:922-6. [PMID: 8335400 DOI: 10.1002/ijc.2910540609] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
683 Semczuk A, Schneider-Stock R, Miturski R, Skomra D, Tomaszewski J, Roessner A, Jakowicki JA. RB protein expression in human endometrial carcinomas--an immunohistochemical study. Pathol Res Pract 2000;196:41-6. [PMID: 10674271 DOI: 10.1016/S0344-0338(00)80020-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
684 Gao X, Honn KV. Recessive oncogenes: current status. Pathol Oncol Res 1995;1:7-22. [PMID: 11173562 DOI: 10.1007/BF02893578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
685 Shannon KM, Le Beau MM, Largaespada DA, Killeen N. Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse. Seminars in Cancer Biology 2001;11:191-9. [DOI: 10.1006/scbi.2001.0372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
686 Zeng Y, Kulkarni P, Inoue T, Getzenberg RH. Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity. J Cell Biochem 2009;107:179-88. [PMID: 19277990 DOI: 10.1002/jcb.22114] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
687 Roth JA, Mukhopadhyay T, Zhang WW, Fujiwara T, Georges R. Gene replacement strategies for the prevention and therapy of cancer. Eur J Cancer. 1994;30A:2032-2037. [PMID: 7734218 DOI: 10.1016/0959-8049(94)00398-o] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
688 El-naggar AK, Hurr K, Kagan J, Gillenwater A, Callender D, Luna MA, Batsakis JG. Genotypic Alterations in Benign and Malignant Salivary Gland Tumors: Histogenetic and Clinical Implications: . The American Journal of Surgical Pathology 1997;21:691-7. [DOI: 10.1097/00000478-199706000-00009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
689 Daly P. Cancer genetics or cancer genomics in the era of genomic medicine? Annals of Oncology 2003;14:iii19-25. [DOI: 10.1093/annonc/mdg743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
690 Mori N, Ohwashi-Miyazaki M, Yoshinaga K, Okada M, Shiseki M, Motoji T, Tanaka J. Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia. Eur J Haematol 2017;98:467-77. [PMID: 28129457 DOI: 10.1111/ejh.12857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
691 Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci USA. 1992;89:9210-9214. [PMID: 1409626 DOI: 10.1073/pnas.89.19.9210] [Cited by in Crossref: 165] [Cited by in F6Publishing: 159] [Article Influence: 5.7] [Reference Citation Analysis]
692 Tsai S, Wear DJ, Shih JW, Lo SC. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci USA. 1995;92:10197-10201. [PMID: 7479753 DOI: 10.1073/pnas.92.22.10197] [Cited by in Crossref: 117] [Cited by in F6Publishing: 97] [Article Influence: 4.5] [Reference Citation Analysis]
693 Herzog CR, Chen B, Wang Y, Schut HA, You M. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas. Mol Carcinog 1996;16:83-90. [PMID: 8645430 DOI: 10.1002/(SICI)1098-2744(199606)16:2<83::AID-MC4>3.0.CO;2-O] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
694 Filippova GN, Lindblom A, Meincke LJ, Klenova EM, Neiman PE, Collins SJ, Doggett NA, Lobanenkov VV. A widely expressed transcription factor with multiple DNA sequence specificity,CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosom Cancer 1998;22:26-36. [DOI: 10.1002/(sici)1098-2264(199805)22:1<26::aid-gcc4>3.0.co;2-9] [Cited by in Crossref: 96] [Article Influence: 4.2] [Reference Citation Analysis]
695 Annab LA, Dong J, Futreal PA, Satoh H, Oshimura M, Barrett JC. Growth and transformation suppressor genes for BHK syrian hamster cells on human chromosomes 1 and 11. Mol Carcinog 1992;6:280-8. [DOI: 10.1002/mc.2940060410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
696 Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E. p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 1995;75:2037-44. [DOI: 10.1002/1097-0142(19950415)75:8<2037::aid-cncr2820750802>3.0.co;2-v] [Cited by in Crossref: 63] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
697 Unek G, Ozmen A, Mendilcioglu I, Simsek M, Korgun ET. The expression of cell cycle related proteins PCNA, Ki67, p27 and p57 in normal and preeclamptic human placentas. Tissue and Cell 2014;46:198-205. [DOI: 10.1016/j.tice.2014.04.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
698 Calixto G, Bernegossi J, Fonseca-Santos B, Chorilli M. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review. Int J Nanomedicine 2014;9:3719-35. [PMID: 25143724 DOI: 10.2147/IJN.S61670] [Cited by in Crossref: 73] [Cited by in F6Publishing: 22] [Article Influence: 10.4] [Reference Citation Analysis]
699 Majewski T, Lee S, Jeong J, Yoon DS, Kram A, Kim MS, Tuziak T, Bondaruk J, Lee S, Park WS, Tang KS, Chung W, Shen L, Ahmed SS, Johnston DA, Grossman HB, Dinney CP, Zhou JH, Harris RA, Snyder C, Filipek S, Narod SA, Watson P, Lynch HT, Gazdar A, Bar-Eli M, Wu XF, McConkey DJ, Baggerly K, Issa JP, Benedict WF, Scherer SE, Czerniak B. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest 2008;88:694-721. [PMID: 18458673 DOI: 10.1038/labinvest.2008.27] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
700 Trosko JE. The Role of Stem Cells and Gap Junctional Intercellular Communication in Carcinogenesis. BMB Reports 2003;36:43-8. [DOI: 10.5483/bmbrep.2003.36.1.043] [Cited by in Crossref: 63] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
701 Santarius T, Kirsch M, Rossi ML, Black PM. Molecular aspects of neuro-oncology. Clinical Neurology and Neurosurgery 1997;99:184-95. [DOI: 10.1016/s0303-8467(97)00025-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
702 Colombo P, Patriarca C, Alfano RM, Cassani B, Ceva Grimaldi G, Roncalli M, Bosari S, Coggi G, Campo B, Gould VE. Molecular disorders in transitionalvs. peripheral zone prostate adenocarcinoma. Int J Cancer 2001;94:383-9. [DOI: 10.1002/ijc.1485] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
703 Ishii H, Baffa R, Numata SI, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Natl Acad Sci USA. 1999;96:3928-3933. [PMID: 10097140 DOI: 10.1073/pnas.96.7.3928] [Cited by in Crossref: 101] [Cited by in F6Publishing: 96] [Article Influence: 4.6] [Reference Citation Analysis]
704 Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 5’ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1995;1:686-692. [PMID: 7585152 DOI: 10.1038/nm0795-686] [Cited by in Crossref: 1277] [Cited by in F6Publishing: 1180] [Article Influence: 49.1] [Reference Citation Analysis]
705 Wei M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G, Nakae D, Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 2002;23:1387-1397. [PMID: 12151359 DOI: 10.1093/carcin/23.8.1387] [Cited by in Crossref: 156] [Cited by in F6Publishing: 128] [Article Influence: 8.2] [Reference Citation Analysis]
706 Thakker RV, Richard Bringhurst F, Jüppner H. Regulation of Calcium Homeostasis and Genetic Disorders that Affect Calcium Metabolism. Endocrinology: Adult and Pediatric. Elsevier; 2016. pp. 1063-1089.e10. [DOI: 10.1016/b978-0-323-18907-1.00061-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
707 Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992;360:313-9. [PMID: 1448148 DOI: 10.1038/360313a0] [Cited by in Crossref: 650] [Cited by in F6Publishing: 547] [Article Influence: 22.4] [Reference Citation Analysis]
708 Tommerup N, Lothe R. Constitutional ring chromosomes and tumour suppressor genes. J Med Genet 1992;29:879-82. [PMID: 1336057 DOI: 10.1136/jmg.29.12.879] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]<